This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Used for control exclusion in common control thyroid runs
E4_THYROID_CTRL_EXCLUSION
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
149794 |
6. Filter based on genotype QC (FinnGen only) |
149794 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Used for control exclusion in common control thyroid runs
based on the number of shared cases.
Similar with more cases:
None
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 149794 | 99508 | 50286 |
| Unadjusted period prevalence (%) | 29.97 | 33.92 | 22.17 |
| Median age at first event (years) | 49.10 | 47.17 | 52.92 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3636
- Matched controls
- 22543
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H04AA01
ATC
glucagon; nasal, parenteral
1284.0
323.0
519
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
323.0
612
*
103
Kela drug reimbursment
Diabetes, insulin-treated
25.1
323.0
732
224
215
Kela drug reimbursment
Diabetes, non-insulin-treated
48.3
323.0
697
110
H03AA01
ATC
levothyroxine sodium; systemic
61.1
323.0
816
106
A10AE04
ATC
insulin glargine; parenteral
98.6
323.0
435
31
A10AE05
ATC
insulin detemir; parenteral
432.7
323.0
432
7
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
216.4
323.0
610
21
T89
ICPC
Diabetes insulin dependent
490.6
323.0
482
7
A07EC02
ATC
mesalazine; oral, rectal
256.3
323.0
564
16
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2629.5
323.0
704
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
498.7
307.7
363
5
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
483.5
298.8
353
5
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
61.3
295.3
405
46
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
+∞
289.5
331
*
L04AX01
ATC
azathioprine; systemic
43.1
273.9
398
64
K51.5
ICD-10 Finland
Left sided colitis
535.2
267.8
316
*
A10AE06
ATC
insulin degludec; parenteral
696.7
263.4
309
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
+∞
253.0
290
*
SPAT1262
SPAT
Handing over of treatment supplies
13.7
244.7
496
257
UJF32
NOMESCO Finland
Coloscopy
8.7
236.4
606
506
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
46.3
232.7
334
49
A07EA06
ATC
budesonide; oral, local oral
89.3
222.6
292
22
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
827.5
212.3
249
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
553.7
211.3
250
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
5.6
199.5
708
933
H02AB06
ATC
prednisolone; systemic
3.4
189.4
1249
2983
K90.0
ICD-10 Finland
Coeliac disease
59.8
188.4
260
29
UJF30
NOMESCO Finland
Ileoscopy through colon
11.3
181.6
399
242
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.5
176.1
490
456
XCK10
NOMESCO Finland
Photography of fundus of eye
17.4
172.5
317
123
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
337.2
171.1
206
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
10.0
168.5
394
270
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
9.1
167.7
414
314
K50.8
ICD-10 Finland
Other Crohn disease
+∞
165.6
191
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
592.9
153.6
182
*
L40.0
ICD-10 Finland
Psoriasis vulgaris
42.8
151.7
221
34
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.0
144.8
723
1326
K50.0
ICD-10 Finland
Crohn disease of small intestine
342.5
131.9
159
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
338.0
130.2
157
*
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
197.5
122.9
152
5
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
117.5
136
*
ZX120
NOMESCO Finland
Intravenous
7.2
115.5
326
303
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
6.1
112.7
361
401
104
Kela drug reimbursment
Thyroid insufficiency
849.9
112.0
132
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
+∞
111.4
129
*
T86
ICPC
Hypothyroidism/myxoedema
50.1
109.4
155
20
H3600, E103
ICD-10 Finland
NA
+∞
106.2
123
*
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
+∞
106.2
123
*
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
103.6
120
*
A10AA01
ATC
NA
396.9
103.3
124
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
101.6
888
2391
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.4
99.0
305
320
A02BC02
ATC
pantoprazole; systemic
2.4
97.2
1122
3516
K51.8
ICD-10 Finland
Other ulcerative colitis
728.7
96.4
114
*
H03BB01
ATC
carbimazole; oral
722.1
95.5
113
*
177
Kela drug reimbursment
Insulin glargine 300 U / ml
+∞
94.0
109
*
K50.1
ICD-10 Finland
Crohn disease of large intestine
702.3
92.9
110
*
D05AX52
ATC
calcipotriol, combinations; topical
14.8
92.0
178
78
101
Kela drug reimbursment
Anterior pituitary hypofunction
124.8
91.7
117
6
A10AA02
ATC
NA
51.8
91.5
129
16
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
91.9
87.7
115
8
A07EA02
ATC
hydrocortisone; rectal
174.4
87.5
109
*
L04AB04
ATC
adalimumab; parenteral
20.9
86.6
149
46
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
649.7
86.0
102
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
+∞
84.5
98
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
636.6
84.3
100
*
A07EC01
ATC
sulfasalazine; oral, rectal
7.5
83.6
228
199
UJF92
NOMESCO Finland
Capsular endoscopy
15.4
81.4
155
65
E03
ICD-10 Finland
Other hypothyroidism
26.1
80.4
130
32
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
+∞
79.3
92
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
65.7
75.7
103
10
RD210
NOMESCO Finland
NA
8.3
75.3
193
152
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
+∞
75.0
87
*
L01BB02
ATC
mercaptopurine; oral
18.5
72.9
130
45
P01BA02
ATC
hydroxychloroquine; oral
9.2
72.2
174
123
H3601, E103
ICD-10 Finland
NA
+∞
71.5
83
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.2
68.7
212
221
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
67.8
506
1204
H01AC01
ATC
somatropin; parenteral
31.6
67.5
104
21
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
12.6
66.2
136
69
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
24.1
64.4
106
28
Z3231
NOMESCO Finland
Registered nurse
2.2
64.0
882
2904
ZXE00
NOMESCO Finland
One hour or less
2.0
60.3
1027
3683
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.4
58.1
244
364
H02AB09
ATC
hydrocortisone; systemic
6.9
58.1
166
155
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.5
58.1
313
585
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
+∞
57.7
67
*
BAA60
NOMESCO Finland
Total thyroidectomy
+∞
57.7
67
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
151.7
57.3
72
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
56.8
66
*
G35
ICD-10 Finland
Multiple sclerosis
422.3
55.9
67
*
WZC30
NOMESCO Finland
Teaching
3.7
53.9
276
494
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
8.2
53.7
137
107
K51
ICD-10 Finland
Ulcerative colitis
74.8
53.1
71
6
4AA12
NOMESCO Finland
NA
87.1
52.5
69
5
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
52.5
61
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
396.5
52.5
63
*
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
39.5
51.1
75
12
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
5.7
50.9
166
186
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
5.9
50.1
159
172
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
9.3
49.4
117
80
CKC12
NOMESCO Finland
Photocoagulation of retina
15.5
49.4
93
38
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
193.2
49.3
61
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
+∞
49.0
57
*
T90
ICPC
Diabetes non-insulin dependent
6.7
48.5
140
133
Z3226
NOMESCO Finland
Physiotherapist
2.4
47.9
497
1409
D69.0
ICD-10 Finland
Allergic purpura
186.6
47.6
59
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
+∞
47.3
55
*
H3603, E103
ICD-10 Finland
NA
+∞
47.3
55
*
D07XC01
ATC
betamethasone, combinations; topical
3.9
46.6
217
357
A02BC01
ATC
omeprazole; systemic
2.6
46.3
393
997
L40.5
ICD-10 Finland
Arthropathic psoriasis
345.2
45.6
55
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
6.5
45.6
135
133
J01MA02
ATC
ciprofloxacin; systemic
2.2
45.0
558
1721
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
19.7
45.0
78
25
P01AB01
ATC
metronidazole; oral, rectal
2.1
44.6
600
1918
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.1
44.3
197
310
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
173.5
44.2
55
*
D94
ICPC
Chronic enteritis/ulcerative colitis
115.3
43.0
55
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.3
42.8
244
474
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
6.2
41.8
127
130
109
Kela drug reimbursment
Multiple sclerosis
+∞
41.3
48
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.8
41.0
197
333
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
40.9
1099
4498
Z3229
NOMESCO Finland
Other healthcare associate professional
3.1
39.9
258
550
C10AA07
ATC
rosuvastatin; oral
7.1
39.6
110
99
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
+∞
39.5
46
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
39.4
174
272
4AB02
NOMESCO Finland
NA
56.6
39.1
54
6
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
30.9
38.4
59
12
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
55.5
38.3
53
6
WX002
NOMESCO Finland
Sedation and analgesia
2.6
38.2
325
822
D05BB02
ATC
acitretin; oral
47.6
37.4
53
7
N02BE01
ATC
paracetamol; systemic, rectal
1.6
37.0
2038
10046
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
+∞
37.0
43
*
R4190
NOMESCO Finland
Nutritional therapy
3.5
36.9
197
364
C10AA05
ATC
atorvastatin; oral
5.2
36.5
128
157
L40
ICD-10 Finland
Psoriasis
16.6
36.2
66
25
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
10.3
35.9
80
49
H36.01
ICD-10 Finland
Diabetic maculopathy
141.1
35.8
45
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
35.6
711
2624
L04AD01
ATC
ciclosporin; systemic
7.8
35.3
92
75
A10AB06
ATC
insulin glulisine; parenteral
+∞
35.2
41
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
35.2
41
*
WW200
NOMESCO Finland
Immunization
5.4
35.1
118
138
M13.9
ICD-10 Finland
Arthritis, unspecified
3.8
35.0
169
287
J01DB01
ATC
cefalexin; oral
1.6
35.0
2493
13012
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
30.3
34.4
53
11
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
34.4
440
1364
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
34.4
695
2571
L88
ICPC
Rheumatoid/seropositive arthritis
6.9
33.9
95
87
L04AC05
ATC
ustekinumab; parenteral
+∞
33.5
39
*
Z2221
NOMESCO Finland
Medical doctor
1.9
33.5
591
2084
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
32.6
38
*
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
48.1
32.6
46
6
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.9
32.0
118
154
K83.0
ICD-10 Finland
Cholangitis
15.1
31.8
60
25
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
5.9
31.6
99
106
A05AA02
ATC
ursodeoxycholic acid; oral
8.8
31.0
75
54
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
+∞
30.9
36
*
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
30.9
36
*
H02AB07
ATC
prednisone; oral
3.2
30.5
184
373
L40.9
ICD-10 Finland
Psoriasis, unspecified
32.1
30.3
46
9
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
230.6
30.3
37
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
+∞
30.1
35
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
30.1
35
*
D05AX02
ATC
calcipotriol; topical
14.7
29.5
56
24
D07AD01
ATC
clobetasol; topical
2.8
29.4
210
478
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
29.4
467
1576
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
29.3
757
3008
Z96.4
ICD-10 Finland
Presence of endocrine implants
+∞
29.2
34
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
14.1
29.0
56
25
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
28.9
532
1895
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
217.9
28.6
35
*
UJD02
NOMESCO Finland
Gastroscopy
5.3
28.0
95
113
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
21.1
27.9
47
14
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
23.5
27.6
45
12
E23.00
ICD-10 Finland
Panhypopituitarism
+∞
27.5
32
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
25.1
27.4
44
11
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
27.3
643
2480
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
27.1
635
2443
WVA20
NOMESCO Finland
Medicine administration
5.8
27.0
85
92
C10AA01
ATC
simvastatin; oral
5.2
26.5
91
110
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.3
26.2
107
156
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
46.3
26.2
37
5
D07AC01
ATC
betamethasone; topical
1.8
26.1
588
2234
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
25.8
30
*
A10AA03
ATC
NA
103.2
25.7
33
*
S91
ICPC
Psoriasis
30.5
25.5
39
8
D05AX03
ATC
calcitriol; topical
38.6
25.4
37
6
A10BA02
ATC
metformin; oral
3.4
25.3
138
259
C09AA02
ATC
enalapril; systemic
3.7
25.1
122
209
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
+∞
24.9
29
*
171
Kela drug reimbursment
Degludekinsuliini
+∞
24.9
29
*
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
27.1
24.8
39
9
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
53.2
24.6
34
*
C09AA05
ATC
ramipril; oral
4.3
24.5
100
146
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
8.4
24.1
59
44
3005
Kela drug reimbursment
Tofacitinib
+∞
24.0
28
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
24.0
131
247
E06.3
ICD-10 Finland
Autoimmune thyroiditis
32.2
23.9
36
7
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.7
23.8
116
200
Z2446
NOMESCO Finland
Social worker
2.0
23.5
322
1021
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.1
23.2
100
154
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
23.2
27
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
23.1
478
1764
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
64.6
23.0
31
*
WX402
NOMESCO Finland
General anaesthesia
1.9
22.9
405
1415
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
22.9
136
273
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
9.2
22.8
53
36
C08CA01
ATC
amlodipine; oral
3.1
22.5
135
274
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
22.3
26
*
H3602, E103
ICD-10 Finland
NA
+∞
22.3
26
*
R11
ICD-10 Finland
Nausea and vomiting
2.1
22.1
292
912
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.7
22.0
107
184
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
7.0
21.9
60
54
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.7
21.8
105
179
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
7.8
21.6
55
44
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
12.0
21.5
44
23
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
21.4
252
749
TAB00
NOMESCO Finland
Lumbar puncture
3.1
21.4
129
262
A02BC05
ATC
esomeprazole; systemic
1.8
21.4
444
1637
J01FF01
ATC
clindamycin; systemic
1.8
21.4
458
1703
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
13.2
21.4
42
20
ZXD05
NOMESCO Finland
Urgent procedure
1.6
21.2
597
2408
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
21.2
305
987
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
6.3
21.1
62
62
L04AB01
ATC
etanercept; parenteral
5.7
20.8
66
73
L04AA13
ATC
leflunomide; oral
8.0
20.7
52
41
107
Kela drug reimbursment
Pernicious anaemia
+∞
20.6
24
*
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
+∞
20.6
24
*
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
+∞
20.6
24
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
20.5
123
248
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
45.3
20.5
29
*
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
7.2
20.5
55
48
M25.5
ICD-10 Finland
Pain in joint
1.6
20.5
595
2417
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.4
20.3
59
58
H43.1
ICD-10 Finland
Vitreous haemorrhage
22.9
20.3
33
9
WX892
NOMESCO Finland
Monitored bed care
2.7
20.2
155
368
A04AA01
ATC
ondansetron; systemic, rectal
3.0
20.1
130
277
K92.1
ICD-10 Finland
Melaena
3.6
20.1
99
173
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
19.9
455
1727
L40.4
ICD-10 Finland
Guttate psoriasis
31.2
19.8
30
6
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
+∞
19.7
23
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
4.7
19.7
73
97
R50.9
ICD-10 Finland
Fever, unspecified
1.7
19.6
515
2035
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
149.7
19.3
24
*
M07.3
ICD-10 Finland
Other psoriatic arthropathies
78.0
19.0
25
*
L63.8
ICD-10 Finland
Other alopecia areata
35.0
19.0
28
5
253
Kela drug reimbursment
NA
+∞
18.9
22
*
3042
Kela drug reimbursment
NA
+∞
18.9
22
*
E10.09
ICD-10 Finland
Insulin-dependent diabetes mellitus - With coma
+∞
18.9
22
*
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
+∞
18.9
22
*
J02AC01
ATC
fluconazole; systemic
1.7
18.9
443
1694
D07AC13
ATC
mometasone; topical
1.7
18.8
484
1899
R4110
NOMESCO Finland
Physiotherapy
1.7
18.7
451
1737
C07AB07
ATC
bisoprolol; oral
1.9
18.5
287
954
C09CA01
ATC
losartan; oral
3.5
18.5
94
169
R53
ICD-10 Finland
Malaise and fatigue
1.7
18.5
474
1858
L04AA29
ATC
tofacitinib; oral
143.4
18.4
23
*
M45
ICD-10 Finland
Ankylosing spondylitis
5.2
18.2
62
75
I10
ICD-10 Finland
Essential (primary) hypertension
2.3
18.2
179
488
3AC01
NOMESCO Finland
NA
19.4
18.2
31
10
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
+∞
18.0
21
*
ZX112
NOMESCO Finland
Subcutaneous
6.4
18.0
52
51
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
18.0
229
704
S01ED51
ATC
timolol, combinations; ophthalmic
6.2
17.9
53
54
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
17.8
106
215
RS221
NOMESCO Finland
NA
5.3
17.7
59
70
A10BK01
ATC
dapagliflozin; oral
11.8
17.7
36
19
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
11.8
17.7
36
19
Z71.8
ICD-10 Finland
Other specified counselling
1.5
17.5
766
3419
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
17.4
340
1227
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
38.9
17.3
25
*
K50
ICD-10 Finland
Crohn disease [regional enteritis]
49.9
17.3
24
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
17.3
150
384
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.8
17.3
357
1310
L04AX07
ATC
dimethyl fumarate; oral
+∞
17.2
20
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
17.2
20
*
4AA33
NOMESCO Finland
NA
+∞
17.2
20
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
17.2
20
*
164
Kela drug reimbursment
Fingolimod
+∞
17.2
20
*
B03BA03
ATC
hydroxocobalamin; parenteral
9.9
17.2
38
24
E0000UV
ATC
NA
1.4
17.1
1252
6172
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
24.1
16.9
27
7
XCD10
NOMESCO Finland
Electrophysiological examination of eye
5.4
16.8
55
64
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
16.7
582
2466
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
16.7
493
2003
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
31.2
16.6
25
5
R2110
NOMESCO Finland
Giving the first information
3.0
16.5
102
212
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
37.4
16.5
24
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
16.3
169
474
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
16.3
19
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.8
16.0
74
123
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.6
16.0
45
43
N06AX11
ATC
mirtazapine; oral
1.6
16.0
550
2321
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
15.7
206
642
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
15.6
299
1070
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
15.6
115
269
J01AA02
ATC
doxycycline; systemic
1.4
15.6
1042
5036
214
Kela drug reimbursment
Severe and chronic narcolepsy
+∞
15.4
18
*
E06.1
ICD-10 Finland
Subacute thyroiditis
+∞
15.4
18
*
TQB05
NOMESCO Finland
Puncture of skin of trunk
12.1
15.4
31
16
OAB50
SPAT
NA
22.3
15.4
25
7
JHA00
NOMESCO Finland
Anal or perianal incision
5.7
15.3
48
53
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
15.3
182
544
K61.0
ICD-10 Finland
Anal abscess
4.2
15.2
63
95
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
15.1
531
2249
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
6.4
15.1
43
42
H46
ICD-10 Finland
Optic neuritis
10.5
15.0
32
19
M01AH05
ATC
etoricoxib; oral
1.4
14.9
780
3597
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.4
14.7
139
374
B01AB05
ATC
enoxaparin; parenteral
2.1
14.7
188
581
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
21.4
14.6
24
7
L40.8
ICD-10 Finland
Other psoriasis
21.4
14.6
24
7
M09.0*L40.5
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
14.6
17
*
XCH00
NOMESCO Finland
Eye pressure measurement
5.3
14.5
48
57
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
23.9
14.4
23
6
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
14.4
198
628
L04AB06
ATC
golimumab; parenteral
6.4
14.4
41
40
ZXA10
NOMESCO Finland
Bilateral
1.7
14.4
352
1357
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
14.4
293
1071
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
14.4
98
219
ZXA00
NOMESCO Finland
Right side
1.7
14.2
327
1237
G47.3
ICD-10 Finland
Sleep apnoea
2.0
14.2
197
628
Z2445
NOMESCO Finland
Psychologist
1.8
14.2
270
965
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
112.1
14.2
18
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
3.0
14.2
86
178
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
14.1
595
2620
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
14.1
612
2712
E34.35
ICD-10 Finland
Abnormal growth retardation
3.6
14.1
68
118
M79.6
ICD-10 Finland
Pain in limb
1.4
14.1
684
3105
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
14.0
242
838
282
Kela drug reimbursment
Sodium oxybat
+∞
13.7
16
*
CL2S4
SPAT
NA
+∞
13.7
16
*
Z45.1
ICD-10 Finland
Adjustment and management of infusion pump
+∞
13.7
16
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
13.7
1163
5824
C02AC05
ATC
moxonidine; oral
22.8
13.7
22
6
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
9.2
13.6
31
21
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.7
13.6
97
223
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.0
13.6
184
582
E03.1
ICD-10 Finland
Congenital hypothyroidism without goitre
105.8
13.4
17
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
13.4
137
383
N06BA07
ATC
modafinil; oral
14.2
13.4
25
11
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.1
13.3
45
55
R76.0
ICD-10 Finland
Raised antibody titre
9.4
13.3
30
20
E14.1
ICD-10 Finland
Unspecified diabetes mellitus, with ketoacidosis
56.0
13.3
18
*
XCK00
NOMESCO Finland
Perimetry
3.2
13.1
75
149
N05AH04
ATC
quetiapine; oral
1.5
13.0
545
2398
N05CF01
ATC
zopiclone; oral
1.7
13.0
265
969
UJK02
NOMESCO Finland
ERCP
13.0
12.9
25
12
H26.2
ICD-10 Finland
Complicated cataract
21.8
12.9
21
6
102
Kela drug reimbursment
Diabetes insipidus
+∞
12.9
15
*
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
+∞
12.9
15
*
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
+∞
12.9
15
*
E23.2
ICD-10 Finland
Diabetes insipidus
+∞
12.9
15
*
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
+∞
12.9
15
*
R73.0
ICD-10 Finland
Abnormal glucose tolerance test
7.1
12.9
34
30
M01AE02
ATC
naproxen; oral, rectal
1.3
12.8
1791
9618
L04AA06
ATC
mycophenolic acid; systemic
4.2
12.8
52
78
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.6
12.7
35
33
N03AX16
ATC
pregabalin; oral
1.9
12.7
207
702
ZY010
NOMESCO Finland
Hospital outpatient
1.7
12.6
291
1102
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
5.7
12.6
39
43
1XC02
NOMESCO Finland
NA
17.1
12.6
22
8
J01DA01
ATC
[U] cefalexin; systemic
1.3
12.6
1469
7685
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
99.6
12.6
16
*
E23.05
ICD-10 Finland
Lack of TSH
99.6
12.6
16
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
12.6
104
262
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.7
12.6
91
212
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
5.0
12.5
43
54
M03BX02
ATC
tizanidine; oral
1.4
12.5
829
3974
D99
ICPC
Disease digestive system other
7.4
12.5
32
27
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
4.0
12.4
53
83
301
Kela drug reimbursment
Growth hormone
9.9
12.4
27
17
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
18.7
12.4
21
7
R4180
NOMESCO Finland
Podiatric therapy
18.7
12.4
21
7
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
12.2
753
3563
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
12.1
533
2366
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
7.8
12.1
30
24
TQW80
NOMESCO Finland
Local dermatologic skincare
3.6
12.1
57
98
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
12.0
255
942
A02BC03
ATC
lansoprazole; oral
1.9
12.0
193
652
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
12.0
14
*
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
12.0
14
*
N07XX04
ATC
sodium oxybate; oral
+∞
12.0
14
*
JFH11
NOMESCO Finland
Laparoscopic colectomy
+∞
12.0
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
11.9
1061
5323
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.5
11.9
45
63
K60.3
ICD-10 Finland
Anal fistula
4.9
11.8
41
52
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
28.0
11.8
18
*
N06AX16
ATC
venlafaxine; oral
1.6
11.8
305
1195
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
11.8
200
690
CK2S4
SPAT
NA
93.3
11.7
15
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
93.3
11.7
15
*
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
93.3
11.7
15
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
35.3
11.7
17
*
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.7
11.7
32
30
RS224
NOMESCO Finland
NA
4.2
11.7
47
70
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
11.7
795
3821
E66.8
ICD-10 Finland
Other obesity
3.0
11.6
71
149
J01MA12
ATC
levofloxacin; systemic
2.0
11.6
153
481
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
11.5
58
106
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
11.4
1466
7735
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.7
11.4
53
90
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.0
11.4
26
18
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.3
11.4
45
66
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
11.3
84
200
XX9XE
NOMESCO Finland
Other ultrasound examination
11.0
11.2
23
13
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
+∞
11.2
13
*
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
11.2
13
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
11.2
13
*
G61.0
ICD-10 Finland
Guillain-Barré syndrome
+∞
11.2
13
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
+∞
11.2
13
*
L04AA31
ATC
teriflunomide; oral
+∞
11.2
13
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
11.2
13
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
11.2
13
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
11.2
13
*
T69
ICPC
Metabolic, Other reason for encounter NEC
+∞
11.2
13
*
C10AX09
ATC
ezetimibe; oral
8.0
11.1
27
21
A10BK03
ATC
empagliflozin; oral
6.4
11.1
31
30
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
8.5
11.1
26
19
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
11.0
380
1596
D11
ICPC
Diarrhoea
1.5
11.0
402
1712
N06AB03
ATC
fluoxetine; oral
1.6
10.9
276
1072
RD120
NOMESCO Finland
NA
33.2
10.9
16
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.8
10.8
73
163
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
8.7
10.8
25
18
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
10.7
1252
6513
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
10.6
161
532
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.6
10.6
82
199
N05BA04
ATC
oxazepam; oral
1.5
10.5
373
1579
XW000
NOMESCO Finland
Bone marrow biopsy
3.1
10.5
61
124
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.5
10.5
39
54
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
21.2
10.5
17
5
J04BA02
ATC
dapsone; oral
21.2
10.5
17
5
N02AA05
ATC
oxycodone; systemic
2.6
10.5
79
190
K04.0
ICD-10 Finland
Pulpitis
1.6
10.5
273
1073
H20
ICD-10 Finland
Iridocyclitis
14.8
10.4
19
8
D01
ICPC
Abdominal pain/cramps general
1.4
10.4
541
2475
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
10.4
346
1441
SPAT1263
SPAT
Sampling
1.3
10.4
1384
7309
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
10.4
161
539
TK800
NOMESCO Finland
Hemodialysis
4.6
10.3
38
52
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
6.0
10.3
30
31
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.8
10.3
46
76
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.5
10.3
51
92
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
10.3
12
*
N86
ICPC
Multiple sclerosis
+∞
10.3
12
*
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
10.3
12
*
L04AA40
ATC
cladribine; oral
+∞
10.3
12
*
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
10.3
12
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
24.9
10.3
16
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
10.2
528
2413
E000001
ATC
NA
1.4
10.2
687
3290
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
9.8
10.2
22
14
N06AB10
ATC
escitalopram; oral
1.4
10.1
585
2725
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
10.1
1797
9829
ZX114
NOMESCO Finland
Intramuscular
4.0
10.1
42
65
ZXA05
NOMESCO Finland
Left side
1.6
10.0
276
1098
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
10.0
114
337
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.5
10.0
49
88
A11CC03
ATC
alfacalcidol; systemic
3.9
10.0
43
69
127
Kela drug reimbursment
Transplant complication
3.3
10.0
52
98
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.8
9.9
35
46
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
9.9
336
1407
L04AC10
ATC
secukinumab; parenteral
11.3
9.9
20
11
SPAT1359
SPAT
Use of symptom diary
3.0
9.9
60
126
RD112
NOMESCO Finland
NA
10.1
9.9
21
13
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
5.0
9.8
33
41
T99
ICPC
Endocr/metab/nutrit disease other
6.5
9.8
27
26
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
9.8
314
1298
SPAT1054
SPAT
Examination of peripheral nervous system
19.9
9.7
16
5
TJF80
NOMESCO Finland
Ostomy education
6.8
9.7
26
24
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.4
9.7
37
53
K76.9
ICD-10 Finland
Liver disease, unspecified
7.1
9.6
25
22
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
4.9
9.6
33
42
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.7
9.6
200
737
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
11.8
9.6
19
10
B03XA02
ATC
darbepoetin alfa; parenteral
7.5
9.6
24
20
K59.1
ICD-10 Finland
Functional diarrhoea
2.1
9.6
113
340
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.1
9.6
111
332
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
2.3
9.6
95
265
N03AX12
ATC
gabapentin; oral
1.9
9.5
148
494
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
9.5
148
494
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.0
9.5
40
63
Z94.0
ICD-10 Finland
Kidney transplant status
4.1
9.5
39
60
H02AB04
ATC
methylprednisolone; systemic
1.9
9.5
139
456
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
15.1
9.5
17
7
N04BC06
ATC
cabergoline; oral (dopamine agonists)
15.1
9.5
17
7
C10AC01
ATC
colestyramine; oral
4.8
9.5
33
43
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
9.5
52
101
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.7
9.5
221
843
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
9.4
11
*
L04AA33
ATC
vedolizumab; parenteral
+∞
9.4
11
*
371
Kela drug reimbursment
Degludekinsuliini
+∞
9.4
11
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
9.4
2236
12609
N06AX12
ATC
bupropion; oral
1.7
9.4
219
835
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
29.0
9.4
14
*
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.2
9.3
100
288
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
9.3
100
288
A46
ICD-10 Finland
Erysipelas
2.0
9.3
119
369
S18
ICPC
Laceration/cut
1.3
9.3
855
4284
S10
ICPC
Boil/carbuncle
2.0
9.3
127
405
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
2.6
9.3
72
177
L04AC13
ATC
ixekizumab; parenteral
40.5
9.2
13
*
JFH10
NOMESCO Finland
Total colectomy and ileostomy
40.5
9.2
13
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
74.6
9.2
12
*
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
74.6
9.2
12
*
XCD20
NOMESCO Finland
Photoangiography of eye
16.6
9.2
16
6
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
9.2
384
1684
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
9.2
355
1532
L63.9
ICD-10 Finland
Alopecia areata, unspecified
6.5
9.1
25
24
N06AX21
ATC
duloxetine; oral
1.9
9.1
141
470
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
9.1
114
352
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
9.1
251
1002
E29.1
ICD-10 Finland
Testicular hypofunction
5.1
9.1
30
37
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
9.0
84
227
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
18.7
9.0
15
5
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
9.0
63
146
WX140
NOMESCO Finland
Parabulbar anesthesy
7.6
8.9
22
18
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
8.9
138
463
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
8.2
8.9
21
16
V03AE01
ATC
polystyrene sulfonate; oral
8.2
8.9
21
16
C07AA05
ATC
propranolol; systemic
1.4
8.8
414
1854
WZA10
NOMESCO Finland
Long statement of health and health related matters
3.7
8.8
39
65
L13.0
ICD-10 Finland
Dermatitis herpetiformis
21.8
8.8
14
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.2
8.7
34
50
H57.1
ICD-10 Finland
Ocular pain
2.3
8.7
81
217
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.3
8.7
79
211
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
8.6
10
*
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
+∞
8.6
10
*
I06.9
ICD-10 Finland
Rheumatic aortic valve disease, unspecified
+∞
8.6
10
*
4AA17
NOMESCO Finland
NA
+∞
8.6
10
*
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
+∞
8.6
10
*
E05.89
ICD-10 Finland
Other thyrotoxicosis
+∞
8.6
10
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
8.5
308
1312
K06.10
ICD-10 Finland
Gingival fibromatosis
37.3
8.5
12
*
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
4.0
8.4
35
55
UJF34
NOMESCO Finland
Left colonoscopy
68.4
8.4
11
*
H221, M083
ICD-10 Finland
NA
68.4
8.4
11
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
5.0
8.4
28
35
H02AA02
ATC
fludrocortisone; oral
12.4
8.3
16
8
T31
ICPC
Metabolic, Medical examin/health eval partial
12.4
8.3
16
8
J05AB11
ATC
valaciclovir; oral
1.8
8.3
159
571
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
8.3
395
1775
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
2.2
8.2
83
233
H26.3
ICD-10 Finland
Drug-induced cataract
17.4
8.2
14
5
S01EA03
ATC
apraclonidine; ophthalmic
17.4
8.2
14
5
F43
ICPC
Eye, Other diagnostic procedure
9.3
8.2
18
12
L80
ICD-10 Finland
Vitiligo
9.3
8.2
18
12
C05AA08
ATC
fluocortolone; rectal, topical
2.4
8.2
70
181
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
8.2
207
808
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.7
8.2
37
63
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.5
8.1
22
21
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
3.5
8.1
39
70
R06AE07
ATC
cetirizine; oral
1.2
8.1
1291
6914
L04AB05
ATC
certolizumab pegol; parenteral
13.3
8.1
15
7
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
20.2
8.0
13
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
20.2
8.0
13
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
20.2
8.0
13
*
S97
ICPC
Chronic ulcer skin
3.1
8.0
45
91
SPAT1281
SPAT
Other administrative function
1.6
7.9
237
963
WW500
NOMESCO Finland
Blood transfusion
2.8
7.9
52
115
R03AC02
ATC
salbutamol; inhalant
1.2
7.9
1394
7544
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
3.4
7.8
39
72
T85
ICPC
Hyperthyroidism/thyrotoxicosis
24.9
7.8
12
*
E06.9
ICD-10 Finland
Thyroiditis, unspecified
24.9
7.8
12
*
E66.9
ICD-10 Finland
Obesity, unspecified
2.4
7.8
70
186
R51.80
ICD-10 Finland
Headache
1.4
7.8
469
2197
J01CA04
ATC
amoxicillin; systemic
1.3
7.8
3158
18748
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
7.7
199
780
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
6.9
7.7
20
18
A07AA09
ATC
vancomycin; oral
6.9
7.7
20
18
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.9
7.7
20
18
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
7.7
9
*
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
+∞
7.7
9
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
+∞
7.7
9
*
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
+∞
7.7
9
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
7.7
9
*
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
+∞
7.7
9
*
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
+∞
7.7
9
*
4AC05
NOMESCO Finland
NA
+∞
7.7
9
*
L03AB07
ATC
interferon beta-1a; parenteral
+∞
7.7
9
*
C03CA01
ATC
furosemide; systemic
1.8
7.7
129
444
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
7.7
209
832
B02.9
ICD-10 Finland
Zoster without complication
2.6
7.7
58
141
J01FA10
ATC
azithromycin; systemic
1.2
7.6
2281
13028
C08CA13
ATC
lercanidipine; oral
5.0
7.6
25
31
M01AC06
ATC
meloxicam; systemic, rectal
1.6
7.6
226
918
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
62.1
7.6
10
*
E23.03
ICD-10 Finland
Lack of ACTH
62.1
7.6
10
*
6BA02
NOMESCO Finland
NA
6.2
7.6
21
21
G03GA01
ATC
chorionic gonadotrophin; parenteral
3.7
7.6
34
58
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
4.5
7.5
27
37
JHD30
NOMESCO Finland
Incomplete incision of fistula-in-ano
16.2
7.5
13
5
A06AD11
ATC
lactulose; oral
1.7
7.5
173
657
K04.08
ICD-10 Finland
Other specified pulpit
1.6
7.5
195
767
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.1
7.5
30
46
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.2
7.5
24
29
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
7.5
624
3073
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.9
7.5
111
368
T82
ICPC
Obesity
2.1
7.4
84
249
XX9XW
NOMESCO Finland
NA
3.6
7.4
34
59
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
7.0
7.4
19
17
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
7.4
101
325
WX110
NOMESCO Finland
Local anesthesy
1.2
7.4
2292
13120
QBA10
NOMESCO Finland
Incision of skin of trunk
3.9
7.4
31
50
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
5.9
7.3
21
22
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.4
7.3
15
9
Z50.1
ICD-10 Finland
Other physical therapy
2.3
7.3
65
174
SPAT1364
SPAT
Health check-up performed during second study year in students of upper secondary schools, vocational schools etc.
0.8
7.3
675
5079
RJ411
NOMESCO Finland
NA
18.6
7.3
12
*
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
18.6
7.3
12
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
7.3
62
162
R01AD12
ATC
fluticasone furoate; nasal
1.3
7.2
803
4107
R42
ICD-10 Finland
Dizziness and giddiness
1.5
7.2
251
1058
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
7.2
132
469
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.2
256
1085
RS121
NOMESCO Finland
NA
4.0
7.2
29
45
M01AB05
ATC
diclofenac; systemic, rectal
1.3
7.2
821
4216
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
7.2
274
1180
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
5.1
7.2
23
28
WX290
NOMESCO Finland
Other blockade of nerve
1.2
7.1
1731
9648
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
7.1
1353
7355
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
7.1
1009
5313
J01FA06
ATC
roxithromycin; oral
1.4
7.1
447
2108
H40.0
ICD-10 Finland
Glaucoma suspect
3.0
7.1
41
85
205
Kela drug reimbursment
Chronic hypertension
2.0
7.1
90
280
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
7.1
108
362
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
7.1
92
289
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
7.1
192
765
Z93
ICD-10 Finland
Artificial opening status
22.8
7.0
11
*
Z93.2
ICD-10 Finland
Ileostomy status
22.8
7.0
11
*
0088X
ICD-9 Finland
Intestinal infections due to other organisms, Other organism, not elsewhere classified
2.8
7.0
45
100
RS220
NOMESCO Finland
NA
3.1
7.0
39
78
F93.89
ICD-10 Finland
Other childhood emotional disorders
1.8
7.0
125
441
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
7.0
495
2380
E22.1
ICD-10 Finland
Hyperprolactinaemia
4.9
7.0
23
29
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
7.0
54
134
D07AB08
ATC
desonide; topical
1.5
7.0
252
1074
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
9.3
7.0
15
10
R01AD09
ATC
mometasone; nasal
1.2
6.9
1029
5444
N05CF02
ATC
zolpidem; oral
1.7
6.9
156
590
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.7
6.9
30
50
Z01.7
ICD-10 Finland
Laboratory examination
1.5
6.9
228
952
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
6.9
8
*
4CJ01
NOMESCO Finland
NA
+∞
6.9
8
*
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
6.9
8
*
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
6.9
8
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
+∞
6.9
8
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
6.9
8
*
K75.4
ICD-10 Finland
Autoimmune hepatitis
+∞
6.9
8
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
+∞
6.9
8
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
1.8
6.9
110
376
R94.6
ICD-10 Finland
Abnormal results of thyroid function studies
5.1
6.8
22
27
M13.0
ICD-10 Finland
Polyarthritis, unspecified
5.1
6.8
22
27
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
6.6
6.8
18
17
D16
ICPC
Rectal bleeding
2.4
6.8
58
150
JF2AB
NOMESCO Finland
Colongraphy with X-ray
14.9
6.8
12
5
H221, M084
ICD-10 Finland
NA
55.9
6.8
9
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
55.9
6.8
9
*
L63.0
ICD-10 Finland
Alopecia (capitis) totalis
55.9
6.8
9
*
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
55.9
6.8
9
*
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.4
6.8
284
1247
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.0
6.8
39
81
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.8
6.7
29
48
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
6.7
77
232
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.9
6.7
19
20
C08CA02
ATC
felodipine; oral
3.3
6.7
34
65
AA1AD
NOMESCO Finland
CT of head and brain
1.5
6.7
217
904
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
9.7
6.6
14
9
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
6.6
1895
10702
XQ800
NOMESCO Finland
Prick test
1.5
6.6
252
1085
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
6.6
311
1396
TNG10
NOMESCO Finland
Puncture of knee
5.4
6.6
20
23
K07.60
ICD-10 Finland
Snapping jaw
1.8
6.6
123
440
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
6.6
51
126
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.4
6.6
419
1982
ZXD20
NOMESCO Finland
Day surgery
1.5
6.5
220
922
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
17.1
6.5
11
*
RJ410
NOMESCO Finland
NA
17.1
6.5
11
*
B34.9
ICD-10 Finland
Viral infection, unspecified
1.6
6.5
177
704
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
6.6
6.5
17
16
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
6.5
219
919
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
6.5
206
854
L04AA01
ATC
[U] ciclosporin; systemic
4.5
6.4
23
32
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.3
6.4
61
168
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.9
6.4
91
297
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
6.4
95
316
E16.19
ICD-10 Finland
Other specified hypoglycaemia
7.1
6.4
16
14
B01AB10
ATC
tinzaparin; parenteral
2.9
6.4
38
81
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
2.6
6.4
45
107
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
6.4
59
162
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
5.9
6.4
18
19
T87
ICPC
Hypoglycaemia
10.1
6.3
13
8
ZX140
NOMESCO Finland
Intra articular
10.1
6.3
13
8
XPX04
NOMESCO Finland
Angioscopy
8.7
6.3
14
10
T28
ICPC
Limited function/disability (T)
8.7
6.3
14
10
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
6.3
237
1019
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
20.7
6.3
10
*
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
2.8
6.3
41
93
F32.1
ICD-10 Finland
Moderate depressive episode
1.5
6.3
214
900
N06AB04
ATC
citalopram; systemic
1.5
6.3
202
838
B81
ICPC
Anaemia vit B12/folate deficiency
6.2
6.2
17
17
RS211
NOMESCO Finland
NA
3.4
6.2
30
55
A04
ICPC
Weakness/tiredness general
1.3
6.2
521
2566
UJH02
NOMESCO Finland
Anoscopy
3.2
6.2
32
62
J05AB01
ATC
aciclovir; systemic
1.4
6.2
278
1237
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
6.2
133
499
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.5
6.2
241
1044
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
6.6
6.2
16
15
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.5
6.1
218
925
SPAT1131
SPAT
Colonoscopy
3.8
6.1
26
43
UJG02
NOMESCO Finland
Proctoscopy
3.3
6.1
30
56
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
4.4
6.1
22
31
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
4.4
6.1
22
31
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.9
6.1
38
82
F43.9
ICD-10 Finland
Reaction to severe stress, unspecified
2.0
6.1
73
225
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
27.9
6.1
9
*
Q21.21
ICD-10 Finland
Atrioventricular duct
27.9
6.1
9
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
27.9
6.1
9
*
T48
ICPC
Metabolic, Clarification/discussion RFE/demand
27.9
6.1
9
*
H3603, E113
ICD-10 Finland
NA
27.9
6.1
9
*
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
27.9
6.1
9
*
L04AA11
ATC
[U] etanercept; parenteral
13.7
6.1
11
5
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
6.1
275
1226
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
6.1
193
800
-64
ICPC
Encounter/prob initiated by provider
3.5
6.0
28
50
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.3
6.0
486
2381
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.0
6.0
74
230
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
6.0
48
122
JAH00
NOMESCO Finland
Laparotomy
3.0
6.0
34
70
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
+∞
6.0
7
*
T89
ICD-10 Finland
NA
+∞
6.0
7
*
M09.0
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
6.0
7
*
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
+∞
6.0
7
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
+∞
6.0
7
*
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
6.0
7
*
M09.2*K51.9
ICD-10 Finland
Juvenile arthritis in ulcerative colitis
+∞
6.0
7
*
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
6.0
7
*
L04AC16
ATC
guselkumab; systemic
+∞
6.0
7
*
M33.0
ICD-10 Finland
Juvenile dermatomyositis
+∞
6.0
7
*
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
+∞
6.0
7
*
2870A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Allergic purpura[PURPURA HENOCH-SCHÖNLEIN]
+∞
6.0
7
*
108
Kela drug reimbursment
Myasthenia gravis
+∞
6.0
7
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012544) pH of Venous blood
7463
23256
1.70
319.73
5.3
3.7
ph
7.4
7.4
0.37
52
105
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
2495
5175
2.49
318.71
1.3
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
1876
3339
2.90
317.81
1.8
1.4
g/l
0.8
0.8
0.27
1424
2514
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
2379
4836
2.54
316.28
1.3
1.3
u/ml
277.3
244.1
5.36
1481
3138
(46235355) HIV 1 and 2 tests - Meaningful Use set
16684
62813
1.45
312.34
2.0
2.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
344
52
33.69
310.42
2.7
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
2355
4810
2.53
310.09
2.7
2.2
ug/min
144.6
98.4
3.27
1497
2832
(3021788) Differential panel - Synovial fluid
1831
3264
2.89
309.30
1.6
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
10440
24485
2.35
307.65
1.6
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
1826
2855
3.30
307.65
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
6288
11992
2.81
307.65
1.9
1.8
g/l
1.3
1.3
1.57
5830
10862
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
3516
5860
3.14
307.65
2.1
1.2
g/l
1.2
1.2
5.98
3361
5566
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
19667
57998
1.98
307.65
1.5
1.2
u/ml
2.6
1.2
23.27
5685
15226
(40761511) CBC panel - Blood by Automated count
64596
304779
1.64
307.65
16.8
10.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
19323
63926
1.72
307.65
8.2
6.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
17583
64906
1.49
307.65
3.3
2.9
ng/l
1538.4
1332.1
5.83
14914
54715
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
35638
133911
1.68
307.65
6.4
5.8
umol/l
10.9
11.8
25.79
33793
126366
(3004588) Protein electrophoresis panel - Serum or Plasma
5255
13496
2.05
307.65
2.1
2.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
26440
100858
1.52
307.65
9.3
8.0
inr
1.2
1.2
3.18
8310
28970
(3015171) Extractable nuclear Ab [Units/volume] in Serum
4165
7548
2.91
307.65
1.3
1.2
u/ml
1.3
0.4
3.99
342
655
(3002032) Base excess in Venous blood by calculation
7279
22348
1.72
307.65
5.3
3.7
mmol/l
1.6
1.8
2.88
5934
18176
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
65863
307501
1.87
307.65
14.4
7.9
u/l
27.1
26.9
0.92
64206
296347
(3020564) Creatinine [Moles/volume] in Serum or Plasma
65768
305674
1.91
307.65
20.6
12.8
umol/l
79.2
75.9
78.85
65745
305493
(3037467) Urinalysis macro (dipstick) panel - Urine
46619
188219
1.71
307.65
5.3
3.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
1539
733
10.85
307.65
5.7
1.2
u/ml
87.0
80.9
0.08
535
136
(3000475) Leukocytes [#/volume] in Synovial fluid
2273
4431
2.65
307.65
1.7
1.5
e6/l
12006.3
15887.2
2.78
1716
3098
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9584
18909
2.81
307.65
2.5
2.0
nmol/l
364.2
386.1
16.93
8849
17435
(3009508) Creatinine [Moles/volume] in Urine
23169
76290
1.79
307.65
4.0
2.9
mmol/l
7.9
8.0
3.98
20002
64189
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
3453
5614
3.22
307.65
2.3
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
10780
30060
1.96
307.65
7.8
5.4
mmol/l
1.1
1.0
6.93
10146
28034
(3019550) Sodium [Moles/volume] in Serum or Plasma
63835
288471
1.97
307.65
19.0
13.2
mmol/l
139.5
139.7
96.75
62344
280545
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
24009
88530
1.56
307.65
3.7
3.0
u/l
32.8
33.6
0.54
22672
84149
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
839
130
33.08
307.65
2.3
1.5
mg/l
9.3
9.9
0.51
689
101
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
1009
111
46.71
307.65
2.7
2.1
au/ml
143.5
137.2
0.05
139
15
(3017181) Myelocytes/100 leukocytes in Blood
8604
17077
2.76
307.65
4.9
3.5
%
0.8
1.0
4.31
2302
4831
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
1117
137
41.95
307.65
7.3
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10783
34947
1.66
307.65
2.3
1.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
7291
22448
1.72
307.65
5.3
3.7
kpa
5.8
5.8
0.70
7060
21789
(3008898) HLA-B27 [Presence]
3576
8515
2.19
307.65
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
2580
4873
2.75
307.65
1.5
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
39551
155320
1.63
307.65
5.6
4.3
mmol/l
7.0
6.5
201.32
36991
143242
(3007164) IgA [Mass/volume] in Serum or Plasma
17467
49765
2.02
307.65
1.6
1.4
g/l
2.4
2.3
9.52
11186
30326
(3025159) Blasts/100 leukocytes in Blood
7847
15174
2.82
307.65
5.0
3.5
%
0.1
0.2
0.59
1850
3727
(3018095) Leukocytes [#/volume] in Urine
24789
92507
1.54
307.65
4.4
3.3
e6/l
79.1
95.1
2.23
18092
63494
(3023368) Bacteria identified in Blood by Culture
18988
66652
1.60
307.65
4.7
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
16440
60520
1.49
307.65
4.2
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
15221
49806
1.69
307.65
1.8
1.6
pmol/l
20902232.6
41429338.3
4.48
12841
41570
(3002179) Metamyelocytes/100 leukocytes in Blood
7971
15320
2.84
307.65
4.6
3.3
%
0.5
0.7
4.82
1711
3441
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
2317
3595
3.34
307.65
1.3
1.1
u/ml
5.2
2.7
0.92
216
155
(3023520) Reticulocytes [#/volume] in Blood
6595
18083
1.93
307.65
2.9
2.4
e9/l
71.9
68.2
8.70
5039
13434
(3006315) Basophils [#/volume] in Blood
40797
125487
2.47
307.65
8.9
4.2
e9/l
0.0
0.0
8.99
36712
106719
(3013115) Eosinophils [#/volume] in Blood
41739
130375
2.45
307.65
9.1
4.5
e9/l
0.2
0.2
0.56
37930
112911
(3009261) Glucose [Presence] in Urine by Test strip
34868
133532
1.62
307.65
4.3
3.1
estimate
0.0
0.0
0.42
7515
22683
(3034770) Mitochondria Ab [Titer] in Serum
3009
5613
2.79
307.65
1.4
1.2
titre
1039.6
613.6
2.05
111
61
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
666
104
32.75
307.65
1.8
1.5
au/ml
123.1
174.4
0.44
87
16
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
3877
9667
2.09
307.65
2.0
1.6
g/l
1.5
1.5
1.04
3348
8226
(3015736) pH of Urine
27315
102150
1.57
307.65
3.9
2.9
ph
5.6
5.8
0.33
12
82
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
1925
2997
3.32
307.65
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
1546
2400
3.31
307.65
1.7
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
15537
52683
1.63
307.65
3.0
2.4
e6/l
5.1
5.8
6.09
13860
45507
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11470
39443
1.56
307.65
2.0
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
2562
4052
3.29
307.65
5.5
6.2
iu/ml
1215.0
2052.9
0.32
329
616
(3026493) Urate [Moles/volume] in Serum or Plasma
18828
66256
1.59
307.65
2.9
2.5
umol/l
3055.2
4421.7
5.59
16642
57959
(40760892) CBC W Ordered Manual Differential panel - Blood
19438
56021
2.03
307.65
6.3
3.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
1515
1155
6.77
307.65
2.7
1.6
nmol/l
19.9
21.0
2.07
1440
1088
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
2274
3806
3.09
307.65
1.3
1.1
u/ml
46.1
24.2
5.94
284
212
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
33291
97270
2.35
307.65
2.7
2.0
nmol/l
75.5
1011.6
0.50
30745
87563
(36660697) Celiac disease serology panel - Serum
6995
21085
1.75
307.65
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
10233
32575
1.69
307.65
1.3
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
3056
5775
2.76
307.65
1.4
1.2
titre
114.2
106.7
0.13
290
532
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
3465
5604
3.24
307.65
2.1
1.2
g/l
0.2
0.2
18.13
3301
5313
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
54994
204987
2.46
307.65
6.4
2.4
pmol/l
15.0
14.4
307.65
51381
185187
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
8693
13223
3.65
307.65
1.3
1.1
iu/ml
174.4
84.1
61.10
3647
4328
(3035350) Ketones [Presence] in Urine by Test strip
34605
131794
1.63
307.65
4.2
3.0
estimate
0.0
0.0
2.33
7624
22595
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
53517
200742
2.32
307.65
9.8
6.1
u/l
77.6
77.7
0.09
51173
187828
(3026782) Osmolality of Urine
14329
49278
1.59
307.65
3.2
2.5
mosm/kgh2o
543.1
561.2
15.56
12505
41530
(3013650) Neutrophils [#/volume] in Blood by Automated count
44532
147915
2.35
307.65
11.5
7.6
e9/l
4.0
4.1
17.87
40235
127068
(3048689) Calprotectin [Mass/mass] in Stool
13408
28676
2.68
307.65
4.1
1.3
ug/g
178.4
98.4
77.02
11366
21461
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
35377
119923
1.96
307.65
8.2
6.0
mmol/l
1.2
1.2
4.11
29817
101418
(3017143) Hepatitis C virus Ab [Presence] in Serum
11911
32728
2.01
307.65
1.7
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
20577
59302
2.06
307.65
2.6
2.0
mg/l
2.9
2.9
2.33
18009
50057
(3023420) DNA double strand Ab [Units/volume] in Serum
1492
1488
5.17
307.65
1.8
1.1
iu/ml
31.3
21.3
1.47
88
30
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5225
3693
7.65
307.65
1.7
1.5
iu/ml
6.9
6.6
0.02
1028
887
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6951
15132
2.47
307.65
1.8
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
13546
37810
2.00
307.65
1.3
1.2
u/ml
21.4
3.1
82.56
5524
14544
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
2817
5688
2.57
307.65
1.8
1.2
iu/ml
11.9
9.7
0.40
95
63
(36304419) Bacteria [Presence] in Urine
18888
69975
1.50
307.65
3.6
2.8
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
4358
8801
2.61
307.65
2.0
1.1
u/ml
13.6
5.3
3.69
241
66
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
6483
14633
2.37
307.65
4.8
3.6
ng/l
94.5
88.9
3.33
5732
12661
(3012095) Magnesium [Moles/volume] in Serum or Plasma
11953
38976
1.66
307.65
3.8
3.5
mmol/l
0.8
0.8
3.77
11176
36407
(3018418) pH of Serum or Plasma
21728
68769
1.86
307.65
5.0
3.6
ph
7.4
7.4
2.08
4408
12597
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
20943
73695
1.62
307.65
2.3
2.0
u/l
190.9
230.9
6.65
19736
69193
(3005719) IgG [Mass/volume] in Serum or Plasma
8076
15392
2.87
307.65
3.0
2.3
g/l
10.8
10.4
6.60
7447
14002
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
11549
30725
2.08
307.65
3.1
2.3
%
22.7
23.3
3.25
9861
26296
(3041096) Erythrocytes [Presence] in Urine by Automated
19257
73681
1.44
307.65
3.8
2.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
53709
243919
1.44
307.65
21.7
13.6
%
13.7
13.6
38.81
52857
238418
(3020779) Urea [Moles/volume] in Serum or Plasma
7195
20707
1.84
307.65
10.1
6.6
mmol/l
10.1
9.2
19.32
6885
19667
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
3684
2789
7.00
307.65
2.2
1.2
iu/l
6.5
7.4
0.07
1582
618
(3023103) Potassium [Moles/volume] in Serum or Plasma
63974
289422
1.97
307.65
19.2
13.3
mmol/l
4.0
4.0
2.59
62392
280866
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
8727
26702
1.75
307.65
4.2
4.2
u/l
238.7
242.9
1.43
8286
25211
(3006504) Eosinophils/100 leukocytes in Blood
37927
118402
2.30
307.65
9.1
4.4
%
2.9
2.8
3.65
36008
109592
(3022096) Basophils/100 leukocytes in Blood
37127
114093
2.32
307.65
9.1
4.4
%
0.7
0.7
50.57
35274
105627
(3019069) Monocytes/100 leukocytes in Blood
38100
119140
2.30
307.65
9.4
4.6
%
8.7
8.4
60.25
36288
110963
(3019198) Lymphocytes [#/volume] in Blood
41496
130152
2.43
307.65
8.9
4.3
e9/l
1.9
2.0
9.37
37808
113194
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
1104
108
52.59
307.65
3.4
2.3
mg/l
8.2
6.8
1.43
892
73
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
56141
250953
1.58
307.65
6.7
4.8
mmol/mol
41.4
38.5
307.65
52486
233545
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
2966
5088
3.04
307.65
1.4
1.1
u/ml
40.2
22.6
2.22
250
142
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
2118
1129
9.76
307.65
1.1
1.1
iu/ml
2.1
2.3
0.20
30
41
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
2250
3701
3.15
307.65
1.3
1.1
u/ml
21.0
11.5
0.60
42
25
(3022948) Iron [Moles/volume] in Serum or Plasma
13262
36417
2.03
307.65
3.0
2.2
umol/l
13.1
14.2
1.27
12363
33719
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
60700
254420
2.24
307.65
7.3
3.1
mu/l
2.1
2.1
0.28
57011
233422
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
8649
8532
5.69
307.65
4.2
1.7
pmol/l
4.5
4.6
1.56
7813
7563
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
14233
40788
1.95
307.65
1.3
1.2
iu/ml
45.7
22.9
15.53
4782
11633
(3019309) Folate [Moles/volume] in Red Blood Cells
13501
41588
1.79
307.65
1.8
1.7
nmol/l
1163.0
1150.1
0.78
10441
31414
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
63897
288452
1.98
307.65
18.5
11.1
mg/l
20.5
24.6
176.94
53601
220306
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
3948
9254
2.23
307.65
1.9
2.0
u/l
38.9
39.5
1.00
3603
8218
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
32044
108613
1.88
307.65
7.3
5.5
mmol/l
1.2
1.2
0.12
29398
98121
(3020682) Albumin/Creatinine [Ratio] in Urine
22276
70280
1.87
307.65
5.0
3.6
mg/mmol
12.4
8.4
13.88
15279
44110
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
3474
6913
2.62
307.65
1.8
1.4
titre
309.8
216.2
1.03
190
171
(3021440) Promyelocytes/100 leukocytes in Blood
8215
16195
2.77
307.65
5.0
3.5
%
0.1
0.1
6.02
2138
4464
(3012516) Albumin [Mass/volume] in Urine
21333
66573
1.88
307.65
4.1
2.9
mg/l
425.6
398.7
0.33
14617
41638
(3002582) Erythrocytes [#/volume] in Urine
21080
78434
1.51
307.65
3.8
2.9
e6/l
61.5
96.6
3.81
16892
58581
(3002030) Lymphocytes/100 leukocytes in Blood
38858
124042
2.26
307.65
9.1
4.4
%
28.2
28.5
7.85
36885
114932
(3024561) Albumin [Mass/volume] in Serum or Plasma
32380
104143
2.03
307.65
6.1
4.3
g/l
35.8
35.8
0.65
30382
96089
(3029937) Albumin [Presence] in Urine by Test strip
19427
69778
1.56
307.65
4.7
3.3
estimate
0.0
0.0
0.46
7570
22194
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
2762
4514
3.18
307.65
1.4
1.1
u/ml
8.7
5.7
0.57
370
244
(3013707) Erythrocyte sedimentation rate by Westergren method
52132
195471
2.23
307.65
5.7
3.0
mm/h
12.0
10.8
63.16
49082
180406
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
24309
95213
1.44
307.65
3.8
3.2
ng/l
86.0
57.8
0.65
16055
59477
(3020630) Protein [Mass/volume] in Serum or Plasma
6327
17101
1.96
307.65
2.3
2.6
g/l
66.5
66.6
0.19
5824
15507
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
662
441
7.67
307.65
3.0
1.9
ug/l
1.1
1.3
0.51
612
425
(3030467) Casts [#/volume] in Urine by Automated count
19356
71267
1.51
307.65
3.7
2.8
e6/l
0.4
0.4
1.87
15205
52083
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
2783
4605
3.14
307.65
1.4
1.1
u/ml
11.2
5.2
3.68
540
405
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
14854
49012
1.67
307.65
1.7
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
33622
115798
1.87
307.65
12.4
7.7
e9/l
0.0
0.0
0.80
28635
93190
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
22652
80666
1.61
307.65
3.1
2.3
u/l
57.0
58.6
2.58
21043
74403
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
59218
263579
1.73
307.65
16.0
10.5
ml/min/173m2
85.5
85.0
4.37
50411
212411
(3018010) Neutrophils/100 leukocytes in Blood
38399
122039
2.25
307.65
8.8
4.3
%
57.2
56.8
5.06
36530
113674
(3037522) Nuclear Ab [Titer] in Serum
13767
29335
2.70
307.65
1.5
1.3
titre
615.4
381.1
31.59
3325
4428
(3021960) Folate [Moles/volume] in Serum or Plasma
15822
54384
1.61
307.65
1.6
1.5
nmol/l
20.1
19.9
0.76
13913
46859
(3001122) Ferritin [Mass/volume] in Serum or Plasma
33208
119829
1.74
307.65
3.4
2.6
ug/l
121.1
116.9
1.58
31093
111689
(3007853) Bacteria identified in Skin by Aerobe culture
9519
29908
1.71
307.65
1.9
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
40647
124883
2.47
307.65
8.9
4.2
e9/l
0.6
0.6
2.28
36582
106254
(3027945) Reticulocytes/100 erythrocytes in Blood
8777
25064
1.88
307.65
3.1
2.4
%
1.8
1.7
9.84
7836
22124
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
7430
21898
1.80
307.65
2.8
2.2
g/l
0.2
0.2
0.11
6940
20309
(3031040) Bacteria [#/volume] in Urine by Automated count
42883
181401
1.48
307.65
4.9
3.9
e6/l
1102.5
1208.9
0.20
631
2549
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7723
20564
2.01
307.65
1.4
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
27615
99992
1.64
307.65
2.1
1.8
pmol/l
95.5
96.0
0.98
15513
52543
(42870588) Differential panel, method unspecified - Blood
29508
81345
2.41
307.65
8.4
4.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
12255
33404
2.03
307.65
3.0
2.2
g/l
2.3
2.4
5.90
11396
30800
(3015377) Calcium [Moles/volume] in Serum or Plasma
22756
82385
1.58
307.65
3.3
3.3
mmol/l
2.3
2.4
51.00
20101
72140
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26554
103599
1.47
307.65
4.4
3.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
34576
132089
1.62
307.65
5.6
4.2
estimate
0.0
0.0
1.23
7861
23260
(3039162) Centromere protein B Ab [Units/volume] in Serum
1489
2080
3.68
307.65
1.4
1.1
u/ml
54.6
33.7
1.66
120
71
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
6152
18365
1.76
305.42
4.3
3.5
mmol/l
1.2
1.2
9.25
5456
15909
(3026008) Bacteria identified in Urine by Culture
19284
74937
1.41
301.98
3.2
2.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
4536
12483
1.90
290.58
1.2
1.1
titre
159.9
270.0
1.94
214
189
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
17336
66490
1.42
289.71
1.8
1.6
mmol/l
1.4
1.4
3.23
14699
56584
(40761536) Microorganisms panel - Urine sediment
6955
21878
1.68
285.82
4.4
3.3
—
—
—
0
0
(3013512) EKG study
18166
70493
1.41
283.01
4.0
3.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
5747
17188
1.75
282.43
3.0
2.5
e9/l
4.2
4.1
0.90
4532
13613
(3009214) Lutropin [Units/volume] in Serum or Plasma
3455
8718
2.06
281.34
1.6
1.3
u/l
8.5
9.2
2.12
2805
7088
(3044889) 12 lead EKG panel
42401
188178
1.34
278.54
3.8
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
8685
29116
1.58
276.82
1.6
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
15379
58153
1.43
275.37
1.9
1.7
mg/l
1.2
1.2
0.20
11660
43605
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
1311
2110
3.19
260.85
1.7
1.4
%
54.8
60.8
4.58
849
1334
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
1926
3884
2.55
259.55
1.3
1.1
titre
166.4
71.7
1.23
66
29
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
2530
5863
2.23
253.51
1.9
2.1
mg/l
10.8
10.9
0.10
2377
5483
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1744
3394
2.64
251.53
3.2
3.3
u/ml
6537.0
3258.3
0.26
103
201
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
3339
8679
2.00
250.55
1.4
1.4
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
330
5
335.67
248.55
3.4
1.4
mg/l
22.3
23.9
—
308
5
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
321
5
326.45
241.54
3.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
6455
20780
1.63
240.37
9.6
8.2
—
—
—
0
0
(3019225) pH of Specimen
6915
22665
1.60
239.55
5.0
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
5002
15046
1.74
239.28
1.3
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
3935
11011
1.86
238.24
2.1
1.4
mu/l
322.9
303.4
1.23
3579
9867
(3044640) Blood type and Crossmatch panel - Blood
20981
85367
1.34
234.83
2.6
2.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
17148
67604
1.37
234.69
4.7
3.7
%
91.2
90.2
5.24
16655
65940
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5105
15533
1.72
234.38
4.4
3.7
kpa
5.1
5.1
1.13
4761
14360
(3048929) Epstein Barr virus Ab [Presence] in Serum
3536
9612
1.91
233.38
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5548
17305
1.68
232.72
2.4
2.3
au/ml
22.3
22.9
0.13
261
1207
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
3705
10241
1.88
232.69
1.1
1.1
u/ml
17.0
7.7
0.55
59
129
(3024354) Oxygen [Partial pressure] in Venous blood
5884
18661
1.65
231.75
4.3
3.3
kpa
4.8
4.6
3.93
5659
18049
(3009343) pH of Capillary blood
5038
15355
1.71
229.73
4.4
3.7
ph
7.4
7.4
3.93
702
1808
(40761535) Cells panel - Urine sediment
6058
19420
1.63
228.74
4.3
2.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
1515
2884
2.70
227.49
1.3
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
4889
14873
1.71
224.21
4.4
3.7
mmol/l
1.4
1.6
1.33
3573
10738
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5117
15783
1.69
223.25
1.3
1.3
au/ml
41.7
48.8
1.16
177
688
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
2629
6516
2.08
223.21
4.5
4.5
mg/l
1.6
1.4
19.58
2451
6036
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
30393
131072
1.30
221.99
4.4
3.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
8405
29362
1.51
218.89
3.0
2.7
umol/l
7.8
8.7
3.03
7293
25365
(3014576) Chloride [Moles/volume] in Serum or Plasma
8687
30654
1.50
215.37
8.0
6.9
mmol/l
104.3
104.6
7.73
8489
30001
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
11682
43752
1.42
212.65
3.1
2.5
e6/l
1.0
1.2
1.65
7062
23818
(3004616) Nuclear Ab [Presence] in Serum
1258
2246
2.87
211.53
1.3
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
1023
1606
3.26
211.25
1.3
1.1
titre
218.5
149.6
1.38
269
134
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
1022
1606
3.26
210.73
1.3
1.1
titre
212.9
118.3
0.76
49
29
(3018677) aPTT in Platelet poor plasma by Coagulation assay
10555
38859
1.44
210.68
2.4
2.1
s
30.0
29.8
1.57
10208
37746
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
1559
3150
2.54
208.98
1.7
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
1168
2012
2.97
208.53
2.6
2.4
e9/l
1.1
1.2
1.31
671
1252
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
416
278
7.62
208.09
1.6
1.4
ug/l
9.1
9.1
0.03
416
278
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
1705
3628
2.42
205.76
3.7
3.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
513
456
5.74
204.73
1.5
1.2
pmol/l
15.1
13.9
2.17
433
384
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
59959
284867
1.37
204.65
5.2
4.2
mmol/l
2.7
2.8
176.61
55929
264689
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2907
7724
1.95
204.34
2.0
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2910
7735
1.94
204.32
2.0
2.4
g/l
7.3
7.3
0.36
2196
5745
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2902
7713
1.94
203.81
2.0
2.4
g/l
3.8
3.8
1.62
2115
5448
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7723
26928
1.51
201.69
1.8
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7760
27095
1.51
201.28
1.9
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7120
24462
1.53
198.93
3.6
3.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
59101
280505
1.36
197.64
4.8
3.9
mmol/l
4.6
4.7
184.12
55393
262383
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
2349
5839
2.07
197.62
1.3
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
693
858
4.12
196.46
1.1
1.1
miu/ml
1564.2
1436.4
1.65
693
858
(3019150) Specific gravity of Urine by Refractometry
14960
59080
1.36
196.35
4.7
3.3
kg/l
1.0
1.0
0.18
2169
9027
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
996
1613
3.16
196.17
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
4044
12104
1.73
195.42
5.8
4.1
mmol/l
23.9
24.1
5.35
3684
10926
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
2407
6067
2.05
195.27
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
2201
5359
2.12
195.12
1.6
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2747
7275
1.95
194.73
2.1
2.4
g/l
3.1
3.0
0.76
2155
5619
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
11488
43492
1.40
194.70
2.9
3.0
mmol/l
2.4
2.4
2.49
9977
37818
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
43285
197143
1.28
194.45
3.6
2.8
u/l
49.6
44.7
20.33
40695
185677
(40768446) Kidney Pathology biopsy report
611
686
4.54
193.65
1.7
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
915
1415
3.31
193.20
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
914
1413
3.31
193.08
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
913
1412
3.31
192.76
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
67724
329754
1.56
192.57
27.6
16.2
e9/l
255.9
251.1
63.19
66556
320380
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
908
1402
3.31
192.16
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
56839
268495
1.33
191.87
4.2
3.5
mmol/l
1.3
1.3
27.45
52768
249071
(40759836) Histone Ab [Presence] in Serum by Immunoblot
905
1399
3.31
191.19
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
906
1402
3.30
191.11
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
1039
1765
3.01
189.74
1.2
1.1
mg/l
45.1
39.9
1.64
863
1481
(40768804) Tissue Pathology biopsy report
25563
109285
1.29
189.44
2.1
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
3481
10063
1.79
188.94
1.2
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
1008
1691
3.05
187.84
1.1
1.1
mg/l
253.7
274.2
1.03
888
1493
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
2169
5337
2.09
187.16
1.6
1.4
u/ml
19.7
19.2
0.06
39
99
(3044941) Cell count panel - Synovial fluid
1443
2966
2.50
186.86
1.4
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
67731
330106
1.55
185.00
27.4
16.1
pg
30.2
30.2
4.90
67039
325267
(3024731) MCV [Entitic volume]
67734
330149
1.55
184.39
27.4
16.1
fl
90.8
90.4
82.79
67042
325293
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
58600
278468
1.34
184.34
4.7
3.8
mmol/l
1.4
1.4
37.00
54647
259519
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
2412
6216
2.00
184.27
2.9
3.5
mg/l
44.4
45.7
0.08
1929
5065
(3026361) Erythrocytes [#/volume] in Blood
67739
330189
1.55
184.15
27.5
16.2
e12/l
4.5
4.5
95.28
66426
319859
(3034860) Kappa light chains.free [Mass/volume] in Serum
2414
6230
2.00
183.70
2.9
3.5
mg/l
79.6
57.0
0.45
1934
5068
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
982
1645
3.05
183.41
1.7
1.3
%
34.0
28.9
3.17
602
1052
(3010813) Leukocytes [#/volume] in Blood
67746
330279
1.55
182.98
27.6
16.2
e9/l
6.8
6.7
16.21
66433
319953
(3016502) Oxygen saturation in Arterial blood
7018
24455
1.50
182.55
8.3
7.7
%
95.6
95.8
0.91
6746
23534
(3004809) Band form neutrophils/100 leukocytes in Blood
1544
3324
2.38
181.67
3.1
3.3
%
1.4
1.6
1.31
1218
2516
(3000963) Hemoglobin [Mass/volume] in Blood
67745
330334
1.55
181.51
27.7
16.3
g/l
135.3
136.7
105.39
67057
325526
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2684
7232
1.91
180.84
2.0
2.4
g/l
10.5
10.2
2.94
2283
5999
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
2348
6037
2.00
180.47
2.9
3.5
ratio
2.7
3.1
0.22
209
455
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
7721
27533
1.47
179.19
8.0
7.3
kpa
5.0
5.1
3.44
7336
26269
(3003396) Base excess in Arterial blood by calculation
7724
27548
1.47
179.11
8.0
7.2
mmol/l
0.9
1.0
2.05
5966
21589
(3027801) Oxygen [Partial pressure] in Arterial blood
7716
27521
1.47
178.86
8.0
7.3
kpa
12.2
12.7
10.44
7330
26254
(3000570) Elastase.pancreatic [Mass/mass] in Stool
2430
6355
1.97
178.22
1.5
1.4
ug/g
269.6
279.7
1.32
1406
3562
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
904
1471
3.14
176.74
1.2
1.1
u/ml
67.6
23.9
—
14
7
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
235
71
16.83
176.39
1.7
1.5
mg/l
1.8
1.6
0.58
202
60
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
3041
8612
1.82
176.08
2.1
2.0
ug/l
2.2
2.3
0.07
2710
7539
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
2037
5034
2.08
173.71
1.3
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
1063
1937
2.81
172.48
1.2
1.2
u/l
61.7
76.1
2.13
725
1272
(3013293) Extractable nuclear Ab [Presence] in Serum
242
86
14.31
170.70
1.7
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
331
212
7.95
170.55
1.7
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
2013
4989
2.07
170.37
1.6
1.4
u/ml
111.2
107.6
0.38
424
1087
(3001019) Free T4 and TSH panel - Serum or Plasma
4555
14605
1.62
169.59
2.2
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
2465
6599
1.92
169.07
2.1
2.6
g/l
0.7
0.9
2.96
2150
5615
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
1997
4955
2.07
168.50
1.4
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
15938
64788
1.32
167.53
2.6
2.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
634
835
3.87
166.66
24.7
31.6
ug/l
114.6
123.0
1.33
528
703
(3014111) Lactate [Moles/volume] in Serum or Plasma
6273
21747
1.51
166.25
7.9
7.0
mmol/l
1.4
1.4
0.31
6006
20942
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
881
1469
3.06
165.77
2.8
2.5
e6/l
480.2
598.5
3.61
740
1195
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
2231
5806
1.98
165.72
2.1
2.3
g/l
0.0
0.0
0.81
2050
5267
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
57209
272104
1.30
163.21
4.7
4.0
mmol/l
6.1
5.8
295.87
52722
250549
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1889
4661
2.08
161.63
1.7
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
309
194
8.10
161.38
1.1
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
263
126
10.61
161.33
1.0
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
857
1429
3.06
161.25
2.8
2.5
e9/l
0.2
0.2
4.13
747
1187
(3004119) Hemoglobin [Mass/volume] in Venous blood
4405
14204
1.61
160.00
4.4
3.2
g/l
128.6
130.8
7.56
4295
13889
(3027135) IgG subclass 1 [Mass/volume] in Serum
1129
2216
2.61
159.93
1.4
1.3
g/l
7.2
6.5
4.57
772
1552
(3024139) IgG subclass 3 [Mass/volume] in Serum
1128
2214
2.61
159.80
1.4
1.3
g/l
0.4
0.4
0.71
772
1561
(3028192) IgG subclass 2 [Mass/volume] in Serum
1128
2215
2.61
159.66
1.4
1.3
g/l
3.0
3.0
0.16
773
1552
(1175426) CD3 cells/100 lymphocytes in Blood
930
1643
2.89
159.15
2.2
2.1
%
74.1
71.3
5.21
895
1583
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
2291
6117
1.93
158.20
1.3
1.4
mg/l
514.9
536.7
0.44
2191
5820
(4062490)
1125
2222
2.59
157.47
1.4
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
916
1620
2.89
156.47
2.2
2.1
%
13.1
13.5
0.25
444
844
(4027681)
818
1351
3.09
156.27
1.3
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
1620
3809
2.18
156.14
1.1
1.1
iu/ml
5765.0
461.6
0.57
467
746
(3026250) Tacrolimus [Mass/volume] in Blood
630
874
3.68
154.86
37.4
35.8
ug/l
7.4
7.4
0.09
580
788
(40760888) Immunoglobulin light chains.free panel - Serum
1852
4635
2.05
152.69
2.9
3.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
2238
6021
1.91
151.10
2.0
2.3
g/l
37.6
38.1
2.19
1960
5125
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
2050
5379
1.96
148.66
2.1
2.4
g/l
0.0
0.0
0.83
1875
4862
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
4702
15675
1.56
148.07
8.0
7.5
mmol/l
24.6
24.7
1.55
4657
15544
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6381
22719
1.46
147.37
8.9
8.0
g/l
121.4
122.8
5.26
6161
21878
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
2022
5299
1.96
147.12
2.1
2.4
g/l
0.0
0.0
0.00
1868
4850
(3038026) Centromere Ab [Units/volume] in Serum
811
1390
2.98
145.99
1.3
1.1
u/ml
49.7
41.5
0.24
51
34
(3010503) CD19 cells [#/volume] in Blood
713
1134
3.21
144.41
2.7
2.5
e9/l
0.3
0.4
0.51
694
1107
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
773
1295
3.05
144.39
1.3
1.1
u/ml
12.2
5.1
1.05
62
59
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
1836
4678
2.01
144.29
3.2
1.5
nmol/l
0.8
0.9
8.05
1480
4011
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
10685
41761
1.35
143.85
3.4
2.7
e6/l
2.8
2.8
0.16
6087
21935
(3017446) Testosterone [Moles/volume] in Serum or Plasma
6358
22743
1.46
143.13
2.8
2.0
nmol/l
12.4
12.5
0.10
5672
20258
(3027273) Bicarbonate [Moles/volume] in Venous blood
3535
11085
1.65
142.86
4.4
3.1
mmol/l
25.0
25.2
2.93
3416
10741
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
793
1363
2.97
142.09
1.3
1.1
u/ml
71.2
58.9
0.34
52
20
(3022313) Gas panel - Capillary blood
3580
11286
1.64
141.70
4.7
3.9
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
793
1367
2.96
141.41
1.3
1.1
u/ml
43.9
35.6
0.33
91
39
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
1138
2391
2.43
140.82
1.1
1.1
au/ml
48.6
67.0
—
9
23
(3003327) Ova and parasites identified in Stool by Light microscopy
3014
9099
1.71
140.15
1.7
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
910
1719
2.70
138.46
1.5
1.2
e6/l
91584.5
142633.8
1.24
634
1166
(1616796) Gas panel - Central venous blood
1976
5247
1.93
138.44
4.1
3.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
2017
5396
1.92
138.30
1.7
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
5688
20099
1.47
135.89
2.8
2.5
ml/min/173m2
66.3
69.7
6.07
2383
7502
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
1147
2469
2.38
134.89
1.1
1.1
au/ml
4.5
26.5
—
8
13
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
2579
7529
1.76
134.62
1.1
1.1
u/ml
9.0
3.4
4.45
323
1043
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
2004
5411
1.90
133.71
1.2
1.4
mmol/l
3.8
3.7
6.46
1876
5085
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
840
1556
2.76
132.42
2.3
2.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
2486
7229
1.77
131.44
3.2
3.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
2118
5864
1.86
131.03
3.6
3.0
mmol/l
24.3
24.5
1.81
1877
5165
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
2161
6030
1.84
130.50
2.2
1.7
pmol/l
192.5
198.7
1.66
2051
5740
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1940
5226
1.91
130.30
1.8
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
3436
10959
1.62
129.61
3.9
2.8
%
1.3
1.3
1.94
3418
10905
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
2393
6909
1.78
129.54
1.9
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6625
24309
1.42
129.37
3.0
2.3
u/l
37.5
45.4
1.27
5664
20872
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
2001
5461
1.88
129.30
1.4
1.6
e6/l
1390.2
2381.8
0.57
1638
4384
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
3367
10702
1.62
128.74
3.9
2.8
%
0.7
0.7
0.50
3252
10256
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
1998
5459
1.88
128.66
1.4
1.5
e6/l
17.0
30.7
2.29
1554
4173
(3037121) Protein [Mass/volume] in Urine
2739
8248
1.71
128.31
3.6
3.2
g/l
0.4
0.3
3.24
1395
3717
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
1036
2178
2.43
128.04
1.1
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
917
1815
2.58
127.85
2.5
2.6
g
0.5
0.7
—
11
10
(21494815) CD4 cells/100 lymphocytes in Specimen
972
1983
2.50
127.70
2.2
2.3
%
46.1
33.9
12.64
158
184
(3022217) INR in Platelet poor plasma by Coagulation assay
8272
31629
1.37
126.57
23.4
22.8
inr
1.3
1.4
2.71
1283
4483
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
2719
8207
1.71
126.28
2.4
2.3
ug/l
346.6
613.8
4.93
2507
7686
(3037756) Immunofixation for Serum or Plasma
1581
4031
2.01
123.92
1.6
1.8
—
—
—
0
0
(3010421) pH of Blood
2194
6253
1.80
123.83
4.5
3.5
ph
7.4
7.4
1.53
1887
5318
(3034891) Synovial lining cells/100 cells in Synovial fluid
536
782
3.49
123.14
1.6
1.3
%
4.1
3.9
0.05
129
163
(3019060) Gas panel - Arterial blood
4512
15522
1.50
122.30
5.4
4.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
1389
3391
2.10
121.94
1.9
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
1645
4302
1.96
120.23
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
679
1176
2.94
120.20
1.1
1.1
u/l
1.0
1.1
0.78
302
516
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
830
1613
2.63
119.84
2.8
2.5
e6/l
736.1
721.6
0.06
383
525
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
1199
2779
2.21
119.47
1.5
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
653
1109
3.00
119.38
1.6
1.5
u/l
5.4
5.8
0.18
326
514
(3044290) Cell count panel - Cerebral spinal fluid
1867
5126
1.87
118.39
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
1219
2860
2.18
118.00
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
2479
7444
1.71
117.15
2.7
2.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
1194
2789
2.19
116.81
1.5
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
4328
14906
1.50
116.48
7.8
6.9
mmol/l
24.4
24.6
1.68
4031
13894
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
3134
10047
1.61
115.52
4.9
4.1
mmol/l
24.5
24.7
2.23
2920
9362
(3005988) Vibrio sp identified in Specimen by Organism specific culture
1178
2760
2.18
114.41
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
1176
2758
2.18
113.95
1.5
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
1942
5469
1.82
113.80
4.6
3.6
kpa
8.7
8.7
0.05
1898
5342
(3042733) HLA Ab [Presence] in Serum
480
685
3.57
113.72
5.1
4.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
1174
2758
2.18
113.29
1.5
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
1929
5442
1.82
112.39
4.6
3.6
kpa
5.0
5.0
0.28
1885
5316
(3012501) Base excess in Blood by calculation
1928
5441
1.82
112.21
4.6
3.6
mmol/l
2.4
2.4
0.11
1305
3550
(3005322) IgE [Units/volume] in Serum or Plasma
4917
17502
1.45
112.20
1.4
1.3
u/ml
274.9
258.9
0.23
4544
16226
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
661
1174
2.87
112.19
1.9
1.2
u/ml
27.4
18.4
3.92
194
122
(3008295) Osmolality of Serum or Plasma
935
1996
2.39
111.93
1.7
1.4
mosm/kgh2o
283.3
279.1
4.79
738
1524
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
3181
10364
1.58
109.56
4.7
3.6
%
49.8
48.3
2.55
3139
10250
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
2852
9065
1.62
108.69
2.0
1.6
nmol/l
40.4
40.8
0.29
2777
8871
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1287
3191
2.06
108.58
1.1
1.1
g/l
1.5
1.5
1.61
1181
2884
(3017354) Segmented neutrophils/100 leukocytes in Blood
929
2019
2.35
107.05
3.1
3.3
%
57.4
58.8
0.87
603
1271
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
530
847
3.19
106.69
1.2
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
622
1107
2.86
105.23
1.8
1.2
u/l
6.1
5.7
0.38
538
925
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
1466
3862
1.94
104.91
1.5
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
1454
3822
1.95
104.70
1.7
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
759
1519
2.55
103.63
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
1584
4306
1.88
103.43
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
1010
2315
2.23
103.31
3.7
3.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
439
633
3.53
102.60
1.7
1.7
u/ml
44571.5
6041.2
0.74
50
75
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
611
1094
2.85
102.32
1.3
1.2
u/l
94.6
92.2
0.14
541
950
(42529406) Shigella sp [Presence] in Stool by Culture
2440
7577
1.65
101.73
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
2433
7551
1.66
101.65
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
5490
20295
1.40
101.43
2.4
2.2
ug/l
7.3
7.7
0.52
4758
17699
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
4005
13974
1.48
100.73
1.7
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
2410
7480
1.65
100.66
1.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
1335
3452
1.98
100.65
1.6
1.4
mmol/l
64.8
63.9
0.26
1077
2699
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
520
853
3.10
100.56
1.6
1.2
mu/l
962.6
498.8
1.27
494
808
(3020876) Protein [Mass/time] in 24 hour Urine
806
1688
2.44
100.46
2.0
1.9
g/24h
1.3
0.9
0.78
58
98
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
4188
14766
1.46
99.93
1.6
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
1127
2743
2.10
99.70
1.5
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7863
30860
1.33
99.45
7.9
6.2
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
526
878
3.05
98.97
1.6
1.2
%
72.6
73.0
0.22
500
833
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
3090
10241
1.55
98.69
2.1
1.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
398
551
3.68
98.29
3.2
3.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
11925
49507
1.26
98.22
4.0
3.4
ng/l
458.7
556.3
1.05
8693
36250
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
590
1061
2.83
98.09
1.3
1.2
u/l
25.4
24.5
0.13
515
901
(3023183) Ammonium ion [Moles/volume] in Plasma
1763
5052
1.79
97.59
2.9
2.7
umol/l
33.3
34.6
1.19
1506
4277
(3028626) Oxygen [Partial pressure] in Capillary blood
2074
6239
1.70
97.20
4.3
4.1
kpa
8.6
8.5
0.29
1947
5826
(3030981) Hyaline casts [#/volume] in Urine by Automated count
3826
13329
1.48
96.85
3.2
2.5
e6/l
0.3
0.3
0.49
3730
12948
(3021901) Oxygen saturation in Capillary blood
1534
4241
1.85
95.15
3.1
2.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
4257
15201
1.45
94.96
10.1
9.4
%
94.0
94.0
0.05
4239
15153
(43055514) Macroprolactin [Presence] in Serum or Plasma
419
618
3.45
94.93
1.5
1.2
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
4250
15180
1.45
94.66
10.0
9.3
%
0.7
0.7
0.38
4215
15100
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
4251
15188
1.44
94.53
9.9
9.2
%
1.4
1.4
0.89
4214
15102
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
1260
3265
1.97
94.44
1.5
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
2842
9333
1.57
94.39
1.9
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
1188
3032
2.00
92.83
1.5
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
1741
5050
1.77
92.54
2.7
2.3
%
16.5
16.7
1.14
933
2519
(3016228) CD19 cells/100 cells in Blood
468
758
3.14
92.36
2.0
2.0
%
8.2
9.2
0.83
456
742
(3009871) Measles virus Ab [Titer] in Serum
426
655
3.31
90.94
1.7
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
458
745
3.13
89.81
2.0
2.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
1183
3060
1.98
89.11
1.9
1.4
mu/l
67.4
62.3
0.34
1069
2738
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
795
1752
2.31
88.93
1.1
1.1
mg/l
287.5
453.7
0.49
716
1583
(3045414) Leukocytes [Presence] in Urine
3253
11177
1.50
87.88
1.9
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
3984
14256
1.44
87.67
1.4
1.3
iu/l
22.4
26.1
9.85
3365
12212
(4035726)
5651
21485
1.36
87.50
1.4
1.4
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
154
85
9.20
87.42
1.1
1.1
u/ml
23.1
21.4
0.10
35
12
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
154
85
9.20
87.42
1.1
1.1
u/ml
29.5
23.3
—
41
9
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
177
121
7.43
87.39
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
2405
7746
1.59
86.59
3.9
3.3
u/ml
0.3
0.3
0.44
1349
4405
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
1478
4177
1.81
85.54
1.6
1.6
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
739
1605
2.35
85.36
2.5
2.2
ml
707.7
664.9
1.54
531
1096
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
1147
2984
1.96
85.04
1.5
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
462
784
3.00
84.73
2.9
2.7
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
506
909
2.83
84.35
2.5
2.2
%
9.2
13.0
7.39
475
856
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
836
1929
2.21
84.26
1.3
1.3
nmol/l
1.3
1.5
4.81
737
1787
(3045424) Erythrocytes [Presence] in Urine
1417
3977
1.82
83.84
1.5
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
766
1713
2.28
82.96
1.1
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
552
1063
2.64
81.24
1.6
1.5
umol/l
21.2
26.4
3.35
523
1022
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
550
1058
2.65
81.11
1.4
1.2
titre
371.4
377.9
0.01
64
29
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
714
1563
2.33
81.09
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
538
1025
2.67
80.77
1.4
1.2
titre
58.3
94.2
1.01
46
93
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
713
1575
2.31
79.39
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
3714
13362
1.43
79.17
10.6
9.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
791
1838
2.19
78.45
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
1669
5030
1.70
77.61
4.6
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
867
2102
2.10
77.52
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
655
1408
2.37
77.40
1.7
1.7
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
269
332
4.12
76.87
5.9
5.9
—
—
—
0
0
(3020891) Body temperature
2756
9413
1.50
76.42
5.6
4.7
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
504
960
2.67
75.74
1.1
1.1
u/l
90.1
83.2
0.63
413
758
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
1514
4475
1.73
75.43
1.6
1.4
nmol/l
0.4
0.4
0.30
1194
3615
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
737
1692
2.22
75.21
1.3
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
567
1153
2.50
75.16
2.5
2.0
min
503.4
501.9
0.12
438
866
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
502
960
2.66
74.89
1.1
1.1
u/l
27.1
23.6
0.40
394
734
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
3545
12821
1.42
73.30
10.2
9.5
mmol/l
24.1
24.3
3.90
3277
12020
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14002
60771
1.21
73.04
1.7
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
7568
30721
1.28
72.77
4.5
4.0
%
32.1
31.9
0.75
5532
21225
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
701
1604
2.23
72.12
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
697
1592
2.23
72.00
1.2
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
272
359
3.85
71.63
1.6
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
2432
8207
1.52
71.29
4.5
4.1
mmol/l
1.4
1.4
1.25
2386
8072
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
475
909
2.66
70.81
2.4
2.2
%
28.6
29.3
0.43
452
864
(3030313) Adrenal Ab [Titer] in Serum
170
145
5.95
70.67
1.1
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
948
2463
1.96
70.60
1.4
1.3
nmol/l
25.9
32.4
0.55
13
19
(3013005) Retinol [Moles/volume] in Serum or Plasma
495
970
2.60
70.57
1.9
2.1
umol/l
2.0
1.9
1.20
462
916
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
934
2415
1.97
70.50
1.8
1.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
1312
3800
1.76
70.07
2.0
1.8
mmol/l
1.7
1.8
2.22
1291
3703
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
1422
4218
1.72
69.98
1.5
1.3
u/l
21.1
24.7
4.01
1161
3529
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
212
232
4.64
69.42
2.3
2.7
mmol/l
1.7
1.0
2.78
155
160
(21494755) Public health laboratory ask at order entry panel
5642
36345
0.77
68.95
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1591
4888
1.66
68.92
1.6
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
5104
19815
1.33
68.08
3.3
2.8
ng/l
200.8
200.4
0.02
4606
17884
(21491868) Cryoglobulin [Mass/volume] in Serum
377
649
2.95
67.67
1.2
1.2
g/l
0.3
0.5
0.41
28
28
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
3433
12554
1.41
66.56
2.4
2.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
388
692
2.85
65.64
2.4
2.2
e6/l
173.5
1054.6
1.59
217
389
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
2799
9885
1.45
65.60
5.7
4.8
%
1.7
1.7
0.72
2627
9247
(3024471) HLA-A [Type]
415
773
2.73
65.05
1.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
998
2727
1.87
64.22
2.2
2.0
pg
32.8
32.7
0.41
989
2708
(4146454)
860
2246
1.95
63.17
3.2
2.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
1757
5660
1.59
63.10
2.4
2.0
g/l
129.9
132.1
2.78
1311
4187
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
552
1208
2.33
62.87
2.4
2.5
u/ml
1053.6
1052.2
0.00
547
1193
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
522
1116
2.38
62.52
1.2
1.1
u/ml
21.8
8.1
1.00
77
97
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
740
1837
2.05
62.38
1.2
1.3
mmol/l
1.9
2.1
2.04
684
1702
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
831
2154
1.97
62.35
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
843
2197
1.96
62.29
1.8
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
824
2131
1.97
62.22
2.0
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
56716
276669
1.17
61.88
19.2
12.1
%
39.8
40.3
33.18
40897
212864
(3024932) HLA-DR beta [Type]
403
760
2.70
61.80
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
942
2561
1.88
61.57
1.6
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
2732
9723
1.44
61.44
5.8
4.9
%
0.9
0.9
0.71
2573
9088
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
698
1706
2.08
61.25
1.5
1.3
umol/l
11.9
12.3
0.69
665
1609
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
738
1853
2.03
60.39
1.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
738
1853
2.03
60.39
1.8
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
738
1853
2.03
60.39
1.8
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
987
2742
1.84
60.38
1.4
1.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
1361
4167
1.67
59.74
2.1
2.2
titre
9.8
6.3
0.36
33
133
(3024263) Appearance of Synovial fluid
481
1012
2.42
59.62
2.1
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
2362
8230
1.47
59.25
3.3
2.7
g/l
3.6
3.6
0.09
2231
7868
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
260
384
3.44
59.03
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
260
384
3.44
59.03
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
260
384
3.44
59.03
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
260
384
3.44
59.03
1.1
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
542
1212
2.28
58.88
1.5
1.6
nmol/l
1.1
1.4
7.98
415
969
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
473
999
2.41
58.17
1.8
1.5
nmol/l
3.3
11.3
0.78
392
832
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
1049
3006
1.78
58.11
1.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
1108
3229
1.75
58.01
2.4
2.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
306
511
3.04
57.80
1.1
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
1115
3260
1.74
57.73
1.3
1.3
nmol/l
0.2
0.2
0.51
62
206
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
540
1218
2.26
57.54
1.1
1.1
nmol/l
7.2
2.5
1.28
148
169
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
1115
3276
1.74
56.77
1.3
1.3
nmol/l
2.9
0.7
0.93
1077
3156
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
3794
14470
1.35
56.68
2.3
2.4
u/l
5685.8
6400.8
0.65
1373
5874
(3043409) Potassium [Moles/volume] in Arterial blood
2075
7106
1.49
56.66
4.8
4.4
mmol/l
3.9
3.9
0.24
1931
6680
(3000034) Microalbumin [Mass/volume] in Urine
773
2024
1.95
56.42
3.3
2.8
mg/l
57.3
44.7
0.62
586
1430
(3041672) Baker's yeast Ab [Presence] in Serum
112
75
7.58
56.25
1.1
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
1200
3613
1.69
56.04
1.4
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
1059
3077
1.76
56.02
7.0
6.0
mg/l
11.4
11.2
0.77
970
2832
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
1312
4051
1.65
55.80
1.1
1.1
u/ml
4.3
2.5
2.82
550
2136
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
1314
4060
1.65
55.73
1.3
1.2
u/ml
4.0
3.6
0.65
648
1787
(3012565) Volume of 24 hour Urine
481
1048
2.34
55.39
2.1
2.2
ml
2019.3
1987.3
0.21
439
934
(3013247) Albumin in CSF/Albumin in Serum or Plasma
293
490
3.04
55.24
1.1
1.1
mg/g
6.6
7.2
0.47
275
471
(3022806) Fractional oxyhemoglobin in Capillary blood
1068
3125
1.74
55.17
1.9
1.7
%
90.0
90.0
0.14
1054
3073
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
680
1716
2.02
54.96
1.2
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
567
1332
2.17
54.95
2.9
2.6
%
41.1
37.3
2.59
211
426
(3047181) Lactate [Moles/volume] in Blood
2250
7886
1.46
54.76
6.5
5.5
mmol/l
1.3
1.3
0.02
1974
6962
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
657
1639
2.04
54.74
1.5
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
1169
3519
1.69
54.64
1.5
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
1014
2935
1.76
54.35
1.3
1.3
—
—
—
0
0
(44790049)
951
2702
1.79
54.20
1.7
1.6
—
—
—
0
0
(44790047)
951
2702
1.79
54.20
1.7
1.6
—
—
—
0
0
(44806118)
951
2702
1.79
54.20
1.7
1.6
—
—
—
0
0
(44790048)
951
2703
1.79
54.14
1.7
1.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
637
1586
2.04
53.37
1.9
1.9
mg/l
4.0
3.7
0.64
601
1514
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
638
1591
2.04
53.23
12.6
11.4
mmol/l
0.6
0.6
4.28
585
1468
(3019230) Fractional oxyhemoglobin in Venous blood
1322
4149
1.63
52.79
4.6
3.2
%
65.8
64.6
1.14
1315
4131
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
1014
2973
1.74
52.04
1.4
1.4
pmol/l
351.4
287.6
1.27
777
2324
(3017704) Immunofixation for Urine
459
1010
2.31
51.77
1.5
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
1331
4216
1.61
51.24
1.3
1.2
u/ml
4.5
3.3
0.91
537
1370
(4268621)
944
2724
1.77
51.15
2.3
2.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
292
513
2.89
50.83
1.2
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
332
632
2.67
50.17
2.0
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
769
2097
1.87
49.90
1.7
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
446
990
2.29
49.37
2.1
2.0
ug/min
116.8
103.3
0.15
109
229
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
942
2749
1.75
49.16
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
530
1273
2.12
48.73
1.5
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
614
1563
2.00
48.54
1.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
558
1373
2.07
48.27
1.4
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
371
764
2.47
48.18
1.2
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
611
1562
1.99
47.76
1.4
1.2
umol/l
5.0
5.6
2.55
563
1453
(3004716) Salmonella sp identified in Stool by Organism specific culture
3982
15668
1.30
47.72
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
900
2623
1.75
47.20
1.5
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5067
31684
0.80
46.99
1.6
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
451
1029
2.23
46.93
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
2705
10073
1.38
46.87
1.6
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
546
1348
2.06
46.84
1.4
1.4
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
79
41
9.78
46.62
1.3
1.3
mg/l
1.7
1.6
0.25
64
35
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
1106
3425
1.65
46.57
3.2
2.8
u/ml
214.0
930.4
1.27
1069
3218
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
495
1180
2.13
46.40
1.2
1.3
%
72.5
63.9
1.05
55
135
(3010838) Calcium [Moles/time] in 24 hour Urine
428
968
2.25
45.46
1.6
1.6
mmol/24h
5.7
5.4
0.16
36
78
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
2401
8835
1.39
44.68
2.8
2.6
%
93.1
91.8
1.75
2236
8237
(3036489) Thrombin time
2757
10385
1.36
44.46
2.4
2.2
s
21.5
21.4
0.32
2383
9003
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
424
965
2.23
44.41
2.0
2.0
umol/l
27.9
28.6
0.67
409
933
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
468
1111
2.14
44.35
1.5
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
470
1119
2.14
44.22
1.5
1.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
405
908
2.27
43.91
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
3306
21596
0.77
43.87
1.4
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
9050
39326
1.19
43.80
1.8
1.8
%
1.5
1.4
19.24
7925
35192
(3007916) DNA double strand Ab [Titer] in Serum
150
183
4.16
43.71
1.5
1.0
titre
289.3
44.8
—
15
5
(3000330) Specific gravity of Urine by Test strip
3185
12297
1.33
43.61
3.8
3.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
529
1332
2.02
43.14
1.6
1.2
mmol/l
33.6
35.6
1.00
468
1155
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
334
695
2.44
42.55
1.2
1.2
—
—
—
0
0
(4010399)
4590
18659
1.26
42.45
1.4
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
1144
3667
1.59
42.03
1.3
1.3
u/l
37.2
31.6
0.55
1021
3162
(3016273) Islet cell 512 Ab [Units/volume] in Serum
134
154
4.42
41.82
1.1
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
917
2784
1.68
41.66
14.5
5.4
mmol/l
8.0
6.9
9.09
773
2247
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
1292
4280
1.54
41.21
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
1593
5519
1.47
41.12
1.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
3944
15802
1.28
41.02
1.1
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
2192
8061
1.39
40.93
3.0
2.6
%
188.0
181.3
2.69
2076
7654
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
430
1020
2.14
40.88
1.9
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
430
1021
2.14
40.78
1.9
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
961
2974
1.65
40.63
2.6
2.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
427
1013
2.14
40.59
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
427
1014
2.14
40.49
1.5
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
340
732
2.36
40.36
1.1
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
324
693
2.38
39.02
1.3
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
590
1605
1.87
38.71
1.2
1.1
ratio
1.1
1.1
0.37
212
558
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
180
278
3.29
38.54
5.7
4.8
ug/min
48.5
44.8
0.26
149
208
(3035947) Staphylolysin Ab [Units/volume] in Serum
453
1124
2.05
38.48
1.1
1.1
iu/ml
3.7
4.2
0.46
30
108
(3022621) pH of Urine by Test strip
4235
17249
1.26
38.43
3.2
2.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
199
330
3.06
38.23
1.4
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
42899
207742
1.11
38.22
3.3
3.2
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
208
356
2.97
37.98
2.9
2.5
mg/l
64.7
36.7
0.76
34
83
(3013727) Leukocytes other/100 leukocytes in Blood
314
671
2.38
37.91
3.4
3.4
%
51.4
52.4
0.30
304
646
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
799
2401
1.69
37.74
1.4
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
362
834
2.21
36.97
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
5833
24713
1.21
36.64
3.8
4.1
ug/l
18.7
26.0
1.10
4666
19693
(3023419) Bacteria identified in Sputum by Culture
882
2751
1.63
36.24
2.6
2.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
669
1934
1.76
36.20
1.2
1.1
nmol/l
371.8
374.7
0.11
563
1663
(3036603) Volume of Urine
557
1521
1.86
36.17
1.6
1.7
ml
2072.5
1943.4
0.69
120
342
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
564
1549
1.85
35.99
1.6
1.4
u/l
13.1
12.2
1.99
545
1503
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
102
105
4.93
35.83
4.2
1.2
pmol/l
92.0
1.6
1.94
42
29
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
501
1325
1.92
35.77
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
414
1022
2.06
35.69
1.1
1.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
278
578
2.44
35.58
1.5
1.3
%
49.7
59.2
3.42
232
497
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
248
493
2.56
34.73
1.2
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
275
580
2.41
34.20
1.5
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
423
1073
2.00
33.97
1.1
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
400
997
2.04
33.66
3.3
3.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
848
2679
1.61
33.17
1.1
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
440
1144
1.96
33.03
2.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
440
1144
1.96
33.03
2.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
440
1144
1.96
33.03
2.0
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1999
7503
1.36
32.96
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
440
1147
1.95
32.79
2.0
1.9
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
84
78
5.46
32.62
9.5
10.4
e6/l
124.7
503.8
0.98
60
57
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
2200
8401
1.34
32.42
3.7
3.4
u/ml
462.8
2356.9
1.68
1882
7225
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
718
2191
1.67
32.14
3.3
2.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
539
1514
1.81
32.13
2.6
3.4
nmol/l
125.8
120.2
0.12
532
1483
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
260
552
2.39
31.93
1.7
2.0
u/l
29.4
45.4
0.91
232
506
(3008037) Lactate [Moles/volume] in Venous blood
1430
5103
1.43
31.72
3.5
2.9
mmol/l
1.6
1.6
0.13
1392
5002
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
311
719
2.20
31.60
1.2
1.2
%
19.6
17.8
0.16
52
115
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
229
460
2.53
31.49
1.2
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
1524
5512
1.41
31.38
7.9
6.5
mmol/l
105.0
105.2
0.89
1380
4955
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
130
185
3.57
31.35
3.5
5.7
mg/l
2.6
2.1
1.89
116
148
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
1526
5522
1.41
31.33
1.4
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
1523
5512
1.41
31.25
7.9
6.5
mmol/l
11.4
11.3
0.49
1378
4955
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
1526
5526
1.41
31.21
1.4
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
328
784
2.13
30.77
1.3
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
605
1783
1.73
30.75
1.2
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
333
802
2.11
30.66
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
570
1653
1.75
30.62
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
19246
90044
1.11
30.47
4.5
4.7
ug/l
2.4
3.4
8.44
17180
81244
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
475
1307
1.85
30.24
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
329
799
2.09
29.69
1.1
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
238
502
2.41
29.68
1.4
1.3
%
41.1
36.5
0.90
162
338
(3001686) Cold agglutinin [Titer] in Serum or Plasma
179
328
2.77
29.25
1.5
1.2
titre
176.5
100.8
0.29
27
25
(1761482) Bacteria [#/volume] in Urine by Culture
1648
6115
1.37
29.22
4.4
3.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
1294
4606
1.43
29.14
3.4
3.3
u/ml
493.0
899.4
1.09
1183
4177
(3042951) Complement C1q Ab [Units/volume] in Serum
73
66
5.61
29.09
1.2
1.1
u/ml
19.2
16.9
0.12
15
11
(3003434) Protein [Mass/volume] in Pleural fluid
878
2893
1.54
28.83
1.6
1.4
g/l
31.7
33.6
3.62
784
2609
(3041354) Potassium [Moles/volume] in Venous blood
848
2774
1.56
28.75
2.6
2.2
mmol/l
4.1
4.0
1.32
841
2751
(3035285) Chloride [Moles/volume] in Venous blood
846
2773
1.55
28.44
2.6
2.2
mmol/l
105.5
105.8
0.76
839
2749
(3009466) Valproate [Moles/volume] in Serum or Plasma
1143
4010
1.45
27.81
5.6
4.9
umol/l
370.9
367.4
0.33
987
3490
(3033705) Calcium.ionized [Moles/volume] in Venous blood
832
2732
1.55
27.77
2.7
2.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
876
2911
1.53
27.72
2.2
1.9
mg/l
27.4
25.4
0.44
238
772
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
496
1424
1.77
27.63
1.2
1.2
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
39
14
14.13
27.52
2.8
1.4
mu/l
2.9
1.8
0.63
39
14
(3022493) Free Hemoglobin [Mass/volume] in Plasma
394
1053
1.90
27.45
6.0
4.8
mg/l
2007.2
2992.6
0.38
297
740
(3001186) Copper [Moles/volume] in Serum or Plasma
254
574
2.25
27.30
1.4
1.3
umol/l
16.7
16.8
0.16
228
511
(3038515) Glucose [Moles/volume] in Venous blood
1327
4805
1.41
27.21
3.7
3.0
mmol/l
8.1
7.3
9.92
1295
4725
(3002256) Pathology report gross observation
7904
35216
1.15
26.96
1.3
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
1103
3868
1.45
26.92
3.1
3.0
nmol/l
0.8
0.8
0.61
795
2989
(3016244) Insulin [Units/volume] in Serum or Plasma
618
1903
1.65
26.84
3.1
3.3
mu/l
27.9
25.9
0.50
581
1784
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
2090
8158
1.31
26.46
1.4
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
2636
10621
1.27
26.09
1.3
1.3
miu/ml
223.5
227.7
0.21
1095
5141
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
300
743
2.05
25.83
1.9
2.4
ug/l
67.8
63.8
0.27
295
728
(3032057) Clostridioides difficile [Presence] in Stool
196
405
2.46
25.59
1.9
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
289
710
2.07
25.42
1.1
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
253
591
2.17
25.22
1.1
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
1042
3661
1.45
25.21
1.8
1.9
titre
6720.0
3097.1
0.57
35
178
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
547
1662
1.67
25.03
2.4
2.3
%
97.9
96.5
0.39
513
1550
(3019977) pH of Arterial blood
441
1261
1.78
24.96
2.7
2.4
ph
7.4
7.4
0.18
153
407
(3013139) Helicobacter pylori Ag [Presence] in Stool
4258
18148
1.20
24.83
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
2322
9276
1.28
24.65
2.6
2.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
243
566
2.18
24.41
1.3
1.2
g/l
39.8
40.7
0.36
136
299
(3025315) Body weight
108
163
3.36
24.12
4.9
4.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
849
2891
1.49
24.06
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
252
600
2.13
24.02
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
252
602
2.13
23.83
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
249
592
2.14
23.82
1.1
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
804
2724
1.50
23.36
3.0
3.2
nmol/l
13.1
6.0
0.51
775
2657
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
543
1680
1.64
23.25
2.9
2.9
ug/l
32.7
24.7
—
9
19
(3051611) Lipemic interference index of Serum or Plasma
769
2586
1.51
23.15
3.6
3.4
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
246
592
2.11
22.87
1.3
1.3
nmol/l
116.0
132.3
0.77
193
435
(3051651) Icteric interference index of Serum or Plasma
492
1493
1.67
22.68
3.8
4.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
780
2645
1.50
22.59
1.6
1.4
e6/l
3727.0
3216.9
0.16
572
1913
(3045142) Bone marrow Pathology biopsy report
744
2503
1.51
22.37
1.3
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
348
958
1.85
22.30
1.1
1.1
ng/l
452.5
495.3
0.06
91
191
(3047189) Immunofixation for 24 hour Urine
344
952
1.84
21.71
1.7
1.8
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
603
1949
1.57
21.68
1.4
1.3
u/l
470.7
538.6
0.29
573
1843
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
152
303
2.55
21.42
1.8
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
452
1363
1.69
21.37
1.5
1.7
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
52
46
5.73
21.21
3.9
3.3
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
56
54
5.26
21.13
6.0
5.3
mmol/l
17.6
17.1
0.21
51
49
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
229
554
2.10
21.06
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
681
2286
1.51
20.73
1.5
1.4
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
112
193
2.94
20.49
2.0
2.3
umol/l
1.3
1.3
0.09
103
171
(3014051) Protein [Presence] in Urine by Test strip
1490
5754
1.32
20.46
2.2
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
283
749
1.92
20.45
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
410
1227
1.70
19.97
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
350
1005
1.77
19.68
1.3
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
464
1442
1.64
19.63
1.4
1.5
ug/l
8.4
7.5
0.30
411
1314
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
322
904
1.81
19.49
2.2
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
322
904
1.81
19.49
2.2
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
1939
7803
1.27
19.45
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
324
920
1.79
18.93
2.2
2.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
239
613
1.98
18.92
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
575
1903
1.54
18.74
1.2
1.2
—
—
—
0
0
(4306422)
1151
4337
1.35
18.70
1.2
1.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
94
154
3.10
18.69
1.6
1.1
pmol/l
16.8
12.2
0.39
86
128
(3034426) Prothrombin time (PT)
316
894
1.80
18.69
1.3
1.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
95
157
3.07
18.64
1.1
1.0
u/ml
5.7
2.4
0.84
12
11
(3036782) Glucose [Moles/volume] in Pleural fluid
617
2082
1.51
18.41
1.4
1.3
mmol/l
6.6
6.1
3.44
567
1912
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
200
485
2.09
18.37
1.8
1.3
nmol/l
5.6
6.6
0.57
186
469
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
223
564
2.01
18.36
1.1
1.1
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
41
33
6.30
18.14
8.5
6.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
1112
4190
1.35
18.09
1.2
1.2
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
168
384
2.22
17.81
1.6
1.5
ug/l
0.4
0.4
0.66
113
265
(40768806) Pleura Pathology biopsy report
659
2273
1.47
17.71
1.6
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
322
933
1.75
17.63
1.2
1.2
g/l
0.3
0.3
0.83
258
740
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1103
4171
1.35
17.54
1.1
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
68
93
3.71
17.50
3.5
3.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
691
2415
1.45
17.38
1.6
1.4
e6/l
45010.6
62352.1
0.86
417
1456
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
148
324
2.32
17.31
1.2
1.1
pmol/l
4.0
9.3
0.47
18
40
(37021550) Renin [Units/volume] in Plasma --upright
185
446
2.11
17.28
1.5
1.2
mu/l
100.9
82.7
0.35
144
330
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
1103
4194
1.34
16.94
1.1
1.1
%
118.1
116.6
0.81
1000
3805
(3003694) ABO and Rh group [Type] in Blood
18229
86946
1.08
16.89
1.5
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
331
981
1.71
16.79
2.2
2.0
—
—
—
0
0
(4024509)
628
2172
1.47
16.68
1.6
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
330
983
1.70
16.46
2.5
2.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
337
1010
1.69
16.44
1.1
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
140
308
2.31
16.23
1.4
1.5
nmol/l
52593.5
313134.6
1.48
116
259
(3001556) Androgen free Index in Serum or Plasma
144
321
2.28
16.22
1.4
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
343
1038
1.68
16.17
3.7
3.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
348
1060
1.67
16.02
2.1
1.9
—
—
—
0
0
(3035880) pH of Pleural fluid
371
1150
1.64
15.98
1.4
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
1207
4694
1.31
15.88
2.2
2.2
umol/l
8.5
6.1
2.61
890
3431
(3002621) Streptococcal DNAse B [Units/volume] in Serum
117
239
2.48
15.86
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
157
367
2.17
15.86
1.1
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
471
1553
1.54
15.71
1.3
1.3
u/l
14.5
13.7
0.25
430
1444
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
604
2099
1.46
15.70
1.7
1.8
—
—
—
0
0
(3000492) Spirometry study
6207
28168
1.13
15.65
1.5
1.4
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
126
270
2.37
15.49
1.9
1.0
u/ml
11.1
6.4
—
6
13
(4034850)
2046
8503
1.23
15.48
11.7
8.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
594
2066
1.46
15.39
1.6
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
565
1946
1.48
15.37
1.4
1.3
u/ml
0.8
1.5
1.30
227
845
(3028679) Herpes simplex virus Ab [Presence] in Serum
478
1592
1.53
15.26
1.2
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
69
106
3.30
15.20
6.0
4.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
1127
4380
1.31
14.93
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
629
2228
1.43
14.83
3.7
3.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
179
453
2.01
14.83
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
1824
7524
1.23
14.83
1.4
1.3
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
35
30
5.92
14.74
1.8
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
79
137
2.92
14.46
1.7
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
131
297
2.24
14.27
1.1
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
291
874
1.69
14.18
1.2
1.2
%
111.9
109.9
0.62
257
791
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
399
1299
1.56
14.14
2.2
1.7
%
144.0
136.5
1.01
366
1233
(44806071)
139
325
2.17
14.10
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
388
1260
1.56
13.91
2.2
2.1
umol/l
128.2
137.9
0.23
206
617
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
249
722
1.75
13.74
2.9
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
249
722
1.75
13.74
2.9
2.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
214
593
1.83
13.69
1.3
1.2
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
32
27
6.01
13.67
9.2
7.7
%
38.8
50.2
1.00
17
16
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
70
118
3.01
13.44
1.2
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
213
604
1.79
12.71
1.7
2.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
199
554
1.82
12.59
1.7
1.6
mmol/l
0.2
0.5
0.57
184
518
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
131
314
2.12
12.57
1.9
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
760
2865
1.35
12.51
1.1
1.1
—
—
—
0
0
(4015189)
200
560
1.81
12.44
2.4
2.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
119
276
2.19
12.37
1.1
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
170
452
1.91
12.37
1.9
2.5
mmol/l
2.4
2.7
0.94
155
414
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
92
194
2.41
11.83
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
116
272
2.16
11.78
1.1
1.1
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
88
182
2.45
11.77
2.3
1.7
nmol/l
14.2
3.2
1.09
79
172
(3010370) Gastrin [Moles/volume] in Serum or Plasma
142
361
2.00
11.74
1.9
1.6
pmol/l
46.4
37.8
0.56
117
311
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
55
87
3.21
11.70
1.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
404
1379
1.49
11.64
1.9
1.7
u/field
2.9
2.4
0.36
304
980
(3045716) Anion gap in Serum or Plasma
327
1066
1.56
11.63
2.5
2.2
mmol/l
9.3
9.1
0.33
242
781
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
149
387
1.95
11.63
1.6
1.3
ng/l
640.4
98.6
0.53
104
236
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
171
466
1.86
11.61
1.3
1.2
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
22
14
7.97
11.57
1.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
384
1300
1.50
11.52
2.4
2.1
umol/l
35.3
49.2
0.74
45
153
(3001964) Herpes simplex virus Ag [Presence] in Specimen
254
781
1.65
11.46
1.4
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
97
213
2.31
11.46
1.3
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8179
38271
1.09
11.39
1.7
1.7
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
301
968
1.58
11.36
2.3
1.7
%
171.2
157.9
1.12
287
910
(3014271) Vancomycin [Susceptibility]
333
1099
1.54
11.25
3.2
2.8
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
209
615
1.72
11.09
1.2
1.2
titre
834.3
445.7
—
7
35
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
100
227
2.23
10.99
1.6
1.7
mg/l
1.1
2.1
1.53
68
149
(3035611) Eosinophils/100 leukocytes in Synovial fluid
65
119
2.77
10.96
1.8
1.3
%
0.8
0.8
0.05
47
93
(3028707) Methadone [Presence] in Urine by Screen method
1591
6685
1.21
10.93
3.1
3.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
147
390
1.91
10.84
1.1
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
105
245
2.17
10.83
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
123
306
2.04
10.82
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
88
190
2.35
10.81
1.2
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
161
441
1.85
10.80
1.5
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
103
239
2.19
10.77
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
136
352
1.96
10.76
1.6
1.3
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
99
226
2.22
10.75
1.3
1.8
mmol/l
158.0
177.5
0.70
87
206
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
2253
9780
1.17
10.74
2.0
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
2192
9497
1.18
10.70
1.4
1.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
395
1367
1.47
10.69
1.6
1.6
iu/ml
1482145.0
1893375.2
0.24
18
122
(3035320) C reactive protein [Mass/volume] in Body fluid
525
1921
1.39
10.50
2.7
2.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
1422
8696
0.83
10.49
1.5
1.5
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
175
498
1.78
10.43
1.4
1.4
%
23.8
22.2
0.28
144
409
(3051339) Copper [Moles/volume] in Blood
62
114
2.76
10.40
1.1
1.2
umol/l
16.4
16.4
0.04
53
96
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
798
3116
1.30
10.39
1.1
1.1
%
93.5
96.5
2.36
752
2923
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
241
751
1.63
10.39
1.5
1.3
%
58.9
63.5
1.11
196
616
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
103
243
2.15
10.37
1.3
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
673
2567
1.33
10.35
2.0
1.8
mmol/l
0.9
26.9
—
7
16
(3033093) Yersinia sp IgM Ab [Titer] in Serum
26
24
5.49
10.33
2.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
26
24
5.49
10.33
1.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
26
24
5.49
10.33
1.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
26
24
5.49
10.33
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
26
24
5.49
10.33
2.0
2.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
26
24
5.49
10.33
2.0
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
1421
8675
0.83
10.30
1.4
1.5
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
85
185
2.33
10.28
1.3
1.2
mmol/l
6.1
6.2
0.04
42
90
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
188
549
1.74
10.28
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
286
934
1.55
10.18
1.1
1.1
%
88.8
91.2
0.52
139
434
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
103
245
2.13
10.17
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
1460
8874
0.83
10.10
1.5
1.5
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
290
953
1.54
10.05
1.2
1.2
%
108.2
106.2
0.32
262
859
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
104
250
2.11
10.02
1.1
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
28
29
4.90
10.00
4.6
3.3
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
209
635
1.67
9.95
1.3
1.3
mmol/l
3.3
3.6
0.68
187
582
(3003338) MCHC [Mass/volume]
52009
259231
1.06
9.80
23.4
14.1
g/l
332.5
333.2
52.39
51663
256959
(3027035) Albumin [Mass/time] in 24 hour Urine
87
196
2.25
9.78
1.2
1.4
mg/24h
286.3
338.6
—
10
32
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
1126
4621
1.24
9.78
1.1
1.1
au/ml
15.2
10.7
0.64
57
325
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
154
431
1.81
9.72
3.9
4.8
u/l
41.4
62.9
1.31
53
166
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
533
1983
1.37
9.68
2.2
1.9
u/field
1.9
2.4
1.04
251
874
(3037556) Urate [Mass/volume] in Serum or Plasma
213
656
1.65
9.65
1.5
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
277
912
1.54
9.55
1.2
1.1
%
89.9
91.0
0.14
135
427
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
2.6
4.5
2.25
58
149
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
1.2
1.3
0.08
61
145
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
1.9
3.0
0.91
73
159
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
1.7
1.9
0.19
58
143
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
1.4
1.9
0.66
75
160
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
0.6
1.1
1.32
64
156
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
1.9
2.2
0.24
75
165
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
1.0
2.4
2.78
66
147
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
95
225
2.14
9.52
1.6
1.7
mg/l
2.4
3.0
0.48
72
155
(3006576) Bicarbonate [Moles/volume] in Blood
271
891
1.54
9.41
6.9
5.9
mmol/l
24.2
25.3
3.44
249
808
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
183
545
1.70
9.40
1.1
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
96
230
2.12
9.36
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
2793
12450
1.14
9.35
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
147
411
1.81
9.33
2.5
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8868
41974
1.08
9.31
2.1
2.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
104
259
2.04
9.20
1.6
1.6
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
160
462
1.76
9.15
1.3
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
269
890
1.53
9.10
2.9
2.9
umol/l
27.6
29.1
1.21
190
689
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
76
167
2.31
9.06
1.1
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
396
1418
1.42
9.04
1.3
1.2
u/l
417.1
304.8
0.52
360
1331
(40762365) Oxygen content in Arterial blood by calculation
133
365
1.85
8.96
2.8
3.3
ml/dl
15.1
14.7
0.63
124
340
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
361
1275
1.44
8.89
1.1
1.1
%
94.8
97.7
0.89
284
1026
(3044416) Complement C4 [Mass/volume] in Pleural fluid
46
78
2.99
8.89
1.1
1.3
g/l
0.1
0.1
0.89
33
63
(3020123) Porphyrins [Interpretation] in Serum or Plasma
62
125
2.52
8.84
1.1
1.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
28
33
4.30
8.76
1.1
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
120
321
1.90
8.74
1.4
1.3
%
58.6
49.7
1.00
61
151
(3006442) Creatine [Moles/volume] in Serum or Plasma
510
1918
1.35
8.71
1.6
1.5
umol/l
67.1
71.6
0.70
26
176
(3002619) Bacteria identified in Specimen by Culture
174
523
1.69
8.69
1.3
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
62
127
2.48
8.58
1.1
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
186
573
1.65
8.49
1.5
1.3
%
25.6
20.6
1.46
168
518
(3011325) HIV 1+2 Ab [Presence] in Serum
58
116
2.54
8.42
1.0
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
122
333
1.86
8.39
4.8
5.4
g/mol
51.4
196.4
0.51
110
307
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
65
138
2.39
8.38
1.4
1.3
pmol/l
16.0
18.6
0.45
52
119
(3042517) Benzodiazepines panel - Urine
142
407
1.77
8.37
2.9
3.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
102
264
1.96
8.19
1.1
1.1
—
—
—
0
0
(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum
22
22
5.07
8.15
1.1
1.0
iu/ml
29.5
—
—
6
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
648
2556
1.29
7.96
1.5
1.5
promille
1.3
1.4
1.04
493
1981
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
1829
10680
0.86
7.83
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
1828
10674
0.86
7.83
1.4
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
376
1371
1.39
7.83
1.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
484
1841
1.33
7.74
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
1821
10621
0.87
7.68
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
1827
10650
0.87
7.65
1.4
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
336
1207
1.41
7.63
2.2
2.2
ug/l
44.0
245.5
1.42
323
1147
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
59
126
2.37
7.55
1.0
1.1
u/l
72.2
105.0
0.24
48
96
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
16
12
6.76
7.53
1.3
1.1
nmol/l
263.8
255.5
0.06
16
12
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
169
529
1.62
7.33
1.6
1.5
nmol/l
0.2
0.2
1.47
131
373
(3008536) Aspergillus sp Ab [Presence] in Serum
153
468
1.66
7.25
2.5
2.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
157
484
1.65
7.23
1.4
1.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
162
504
1.63
7.20
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
950
5806
0.83
7.12
1.6
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
115
326
1.79
7.11
2.9
3.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
1971
11367
0.88
7.09
1.5
1.5
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
44
84
2.66
7.03
1.2
1.0
mg/l
0.1
0.5
0.49
37
77
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
172
547
1.60
7.02
1.2
1.2
pmol/l
295.1
327.3
0.37
126
413
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9672
46365
1.07
7.02
2.2
2.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
114
324
1.78
7.00
1.4
1.3
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
98
266
1.87
6.94
1.6
1.6
ug/l
105.7
107.9
0.07
77
222
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
153
475
1.63
6.88
5.1
6.5
%
66.9
71.7
1.12
119
380
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
179
578
1.57
6.87
1.3
1.3
ug/l
241.1
292.0
0.13
96
309
(44813793)
532
2088
1.29
6.87
1.1
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
82
210
1.98
6.86
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7367
35019
1.07
6.84
1.5
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
37
65
2.89
6.83
1.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
183
595
1.56
6.82
1.2
1.2
%
74.3
76.9
0.23
60
146
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
331
1213
1.38
6.77
1.2
1.3
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
35
60
2.96
6.73
4.4
9.0
ml/dl
12.9
12.2
0.37
29
45
(3001893) Eosinophils/100 leukocytes in Pleural fluid
196
650
1.53
6.71
1.5
1.3
%
3.3
2.9
0.18
166
548
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
183
598
1.55
6.69
1.3
1.2
%
79.1
89.6
1.54
63
151
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
1154
4943
1.19
6.64
1.3
1.3
ug/l
3.5
3.9
0.92
1052
4491
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
264
934
1.43
6.59
2.5
2.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
64
152
2.14
6.51
1.1
1.1
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
49
104
2.39
6.41
1.6
1.8
ng/l
180.9
201.5
0.97
42
92
(3020491) Glucose [Moles/volume] in Blood
525
2077
1.28
6.41
1.9
1.7
mmol/l
7.1
6.4
5.19
384
1564
(3014891) Appearance of Pleural fluid
100
281
1.80
6.41
1.9
1.6
—
—
—
0
0
(3035082) Kappa light chains [Mass/volume] in Urine
28
43
3.30
6.37
1.0
1.2
g/l
0.4
0.0
—
8
17
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
839
5127
0.83
6.34
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
618
2503
1.25
6.24
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
1343
5862
1.16
6.18
3.9
3.0
mg/l
26.0
27.3
0.64
828
3708
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
67
166
2.05
6.16
4.2
4.6
—
—
—
0
0
(4094501)
1593
7043
1.15
6.16
1.1
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
80
212
1.91
6.13
2.6
3.2
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
234
822
1.44
6.11
2.4
1.8
e6/l
1043.5
4665.4
1.53
170
553
(3018291) Platelet Ab [Presence] in Serum
24
34
3.58
6.10
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
2385
10828
1.12
6.09
3.3
3.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
703
2900
1.23
6.03
1.4
1.4
mmol/l
12.4
11.5
1.29
230
522
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
187
630
1.51
6.01
1.4
1.3
%
107.1
105.0
0.33
182
592
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
320
1192
1.36
5.99
2.4
2.5
umol/l
57.0
53.2
1.22
264
1031
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
140
442
1.61
5.96
2.8
2.3
mmol/l
8.4
7.0
1.62
88
271
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
495
1964
1.28
5.95
1.6
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
910
5484
0.84
5.93
1.2
1.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
48
105
2.32
5.93
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
157
512
1.56
5.85
2.6
2.6
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
467
1845
1.28
5.82
1.3
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
54
126
2.17
5.78
1.1
1.0
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
41
85
2.45
5.67
1.0
1.0
u/ml
0.1
0.1
0.01
13
32
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
32
58
2.80
5.66
1.2
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
105
312
1.71
5.64
2.4
2.7
pmol/l
60.9
62.4
0.06
86
269
(3021162) Amylase [Enzymatic activity/volume] in Specimen
119
366
1.65
5.64
2.8
2.8
u/l
2899.1
1574.5
0.46
111
324
(3002331) Protein [Mass/volume] in Peritoneal fluid
153
502
1.55
5.58
1.6
1.3
g/l
24.1
40.8
0.79
111
395
(3011048) Pyruvate [Moles/volume] in Blood
67
173
1.96
5.57
1.3
1.4
umol/l
82.5
83.6
0.09
59
158
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
66
172
1.95
5.36
1.1
1.1
iu/ml
22.3
10.6
0.64
20
49
(3026692) Albumin [Mass/volume] in Peritoneal fluid
168
569
1.50
5.33
1.5
1.4
g/l
13.0
13.5
0.30
120
444
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
52
124
2.13
5.32
4.0
4.3
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
44
98
2.28
5.27
1.0
1.0
u/ml
0.1
0.1
0.03
16
42
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9813
47450
1.06
5.27
1.5
1.5
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
42
92
2.31
5.21
1.6
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
63
164
1.95
5.15
2.1
2.5
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
50
119
2.13
5.15
3.9
4.3
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
54
133
2.06
5.11
1.1
1.0
u/l
2.8
3.3
0.15
13
21
(3020650) Glucose [Presence] in Urine
209
747
1.42
5.06
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
1123
4917
1.16
5.05
1.2
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
206
735
1.42
5.04
2.2
1.8
e6/l
10392.1
14012.5
0.31
116
400
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
25
42
3.02
5.03
1.4
1.3
e6/l
18.4
84.8
1.52
19
30
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
58
148
1.99
5.02
1.7
1.4
%
10.7
12.4
0.25
45
101
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
78
2.41
4.99
5.1
6.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
465
1875
1.26
4.98
1.1
1.1
iu/ml
8.2
8.2
0.01
111
500
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
186
655
1.44
4.90
1.2
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
57
146
1.98
4.89
1.1
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
101
310
1.65
4.89
1.6
1.3
%
15.7
10.3
1.08
53
159
(3002523) Influenza virus A Ag [Presence] in Specimen
1193
5264
1.15
4.85
1.1
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
119
383
1.58
4.78
1.1
1.0
ug/l
79.6
82.5
0.28
97
326
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
63
169
1.89
4.76
1.1
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
385
1529
1.28
4.70
1.2
1.2
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
121
393
1.56
4.69
1.1
1.1
u/ml
0.1
0.4
0.91
70
254
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
63
170
1.88
4.69
1.7
1.4
%
29.7
41.0
1.23
46
107
(3003740) Influenza virus B Ag [Presence] in Specimen
1189
5263
1.15
4.65
1.1
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
137
1020
0.68
4.61
3.2
3.1
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
11
7
7.97
4.61
1.1
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
137
1019
0.68
4.59
6.4
6.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
74
212
1.77
4.58
1.1
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
203
737
1.40
4.55
1.8
1.7
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
72
205
1.78
4.55
1.4
1.3
ml/s/173m2
1.2
1.7
0.72
53
136
(40765096) Chromosome analysis panel by Banding
190
684
1.41
4.48
1.2
1.1
—
—
—
0
0
(4212803)
67
188
1.81
4.45
1.1
1.1
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
33
70
2.39
4.43
1.1
1.1
g/l
0.2
0.2
0.01
27
55
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
123
407
1.53
4.42
1.1
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
34
74
2.33
4.33
1.0
1.2
nmol/l
232.3
273.8
0.59
34
74
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
105
337
1.58
4.31
1.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
37
84
2.23
4.31
1.4
1.3
nmol/l
530.6
497.9
0.10
37
84
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
62
172
1.83
4.28
1.1
1.2
%
20.5
25.9
0.27
16
49
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
48
122
1.99
4.25
1.4
1.3
u/l
2145.5
742.4
0.41
41
104
(3006969) Lambda light chains [Mass/volume] in Urine
23
41
2.84
4.25
1.0
1.1
g/l
0.0
0.1
0.50
11
18
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
209
774
1.37
4.21
1.8
1.6
iu/ml
221.8
609.2
—
5
6
(40758047) Lysozyme [Mass/volume] in Pleural fluid
66
188
1.78
4.20
1.3
1.1
mg/l
8.5
9.5
0.34
61
175
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
666
3990
0.84
4.20
3.6
3.6
u/ml
30.2
38.7
1.26
646
3843
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
85
262
1.65
4.12
1.3
1.3
u/l
453.8
210.0
0.27
58
196
(3006462) Nitrate [Presence] in Urine
323
1280
1.28
4.08
3.6
2.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14686
72097
1.04
4.08
4.0
4.1
%
22.1
21.9
0.87
6571
33402
(3044007) Cell count panel - Peritoneal fluid
180
657
1.39
3.98
2.2
1.9
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
49
129
1.93
3.97
1.1
1.1
u/field
1.3
1.0
1.09
31
86
(3017400) Magnesium [Moles/volume] in Urine
27
55
2.49
3.96
1.2
1.3
mmol/l
3.0
3.2
0.15
22
42
(4211845)
351
1414
1.26
3.90
3.5
2.5
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
63
182
1.76
3.86
2.4
1.7
ug/g
174.1
161.3
0.25
53
164
(3050129) First trimester maternal screen panel - Serum or Plasma
2448
13462
0.92
3.78
1.5
1.4
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
43
110
1.98
3.78
1.2
1.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
53
146
1.84
3.78
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
2665
12488
1.08
3.73
2.5
2.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
115
392
1.49
3.68
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
79
247
1.62
3.67
2.4
2.1
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
341
1383
1.25
3.62
1.9
2.0
ug/l
4.1
3.5
0.35
298
1227
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
93
304
1.55
3.61
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
707
3076
1.17
3.60
1.8
2.0
ug/l
21.5
24.8
1.26
688
3021
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
69
210
1.67
3.56
1.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
177
658
1.36
3.55
9.0
7.2
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
20
37
2.74
3.51
1.1
1.1
nmol/24h
109.8
86.0
0.61
20
37
(3041184) Isoniazid [Presence] in Urine
15
23
3.31
3.50
2.3
2.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
192
726
1.34
3.47
2.2
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
79
251
1.60
3.47
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
331
1349
1.24
3.39
2.0
2.1
ug/l
2.5
2.2
0.34
274
1144
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
42
112
1.90
3.34
1.1
1.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
364
1503
1.23
3.32
1.0
1.0
ng/l
36.0
43.4
2.55
245
1066
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
362
1494
1.23
3.32
1.0
1.0
ng/l
289.7
344.9
1.28
252
1077
(3046861) Legionella sp Ag [Presence] in Urine
43
116
1.88
3.31
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
251
993
1.28
3.31
1.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
363
1500
1.23
3.29
1.0
1.0
ng/l
807.5
722.3
2.68
241
1053
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
69
215
1.63
3.29
1.1
1.1
—
—
—
0
0
(3021367) Citalopram [Moles/volume] in Serum or Plasma
24
51
2.39
3.28
1.3
1.4
nmol/l
152.8
130.3
0.23
15
33
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
161
600
1.36
3.22
1.2
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
161
600
1.36
3.22
1.2
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
161
601
1.36
3.19
1.2
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
28
65
2.18
3.18
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
2041
9533
1.09
3.15
1.4
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
484
2897
0.85
3.14
1.5
1.5
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
70
222
1.60
3.13
1.2
1.3
nmol/l
16.9
16.9
0.01
20
57
(3046682) IgA [Presence] in Skin by Immunofluorescence
15
25
3.04
3.13
1.1
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
155
578
1.36
3.11
9.4
6.9
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
63
195
1.64
3.10
2.4
2.2
%
61.7
59.0
0.21
43
116
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
2314
12639
0.93
3.09
1.9
1.9
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
112
395
1.44
3.09
1.2
1.2
mmol/l
1.6
1.6
0.02
72
241
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
32
80
2.03
3.05
1.0
1.1
u/field
1.2
1.2
0.01
13
54
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
55
165
1.69
3.04
1.1
1.0
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
65
204
1.62
3.04
1.7
2.7
mmol/l
20.8
21.1
0.05
55
180
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
392
1648
1.21
3.03
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
3771
20232
0.94
2.99
1.5
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
107
762
0.71
2.96
1.9
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
417
1769
1.20
2.94
1.7
1.8
—
—
—
0
0
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
8
7
5.79
2.93
1.0
1.0
—
—
—
0
0
(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid
7
5
7.10
2.92
2.7
1.6
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
42
362
0.59
2.91
1.0
1.0
mu/l
9.9
8.9
0.46
33
302
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
69
223
1.57
2.89
1.2
1.1
u/l
18.5
21.0
0.42
52
136
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
325
1349
1.22
2.88
1.1
1.1
u/ml
5.6
10.6
2.74
58
250
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
606
2658
1.16
2.87
1.4
1.3
pmol/l
171.0
87.8
0.40
267
738
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
78
261
1.52
2.82
1.4
1.4
%
68.8
71.2
0.27
62
218
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
16
30
2.70
2.78
1.0
1.1
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
9
10
4.56
2.77
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6993
34086
1.04
2.74
1.8
1.8
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
53
163
1.65
2.72
1.1
1.1
s
36.3
37.4
0.44
41
139
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
46
136
1.71
2.71
1.2
1.7
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
8
8
5.07
2.70
1.1
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
8
8
5.07
2.70
1.1
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
80
273
1.49
2.66
1.3
1.2
—
—
—
0
0
(3017166) Chili Pepper IgE Ab [Units/volume] in Serum
22
50
2.23
2.66
1.0
1.0
u/ml
0.1
0.0
0.38
16
39
(3003721) Smooth muscle Ab [Units/volume] in Serum
55
172
1.62
2.65
1.1
1.1
u/ml
2.5
2.1
—
7
14
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
88
307
1.45
2.63
2.2
1.9
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
43
126
1.73
2.62
1.1
1.1
—
—
—
0
0
(4198724)
418
1796
1.18
2.60
2.4
2.4
—
—
—
0
0
(3024316) Viscosity of Plasma
41
119
1.75
2.59
1.4
1.9
mpas
1.5
1.7
1.10
21
75
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
60
462
0.66
2.59
1.2
1.2
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
44
131
1.70
2.55
1.6
1.2
%
0.6
1.6
1.31
31
82
(40763480) Human metapneumovirus Ag [Presence] in Specimen
41
120
1.73
2.52
1.7
1.5
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
88
310
1.44
2.52
1.3
1.3
mmol/l
1.4
1.4
0.03
51
205
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
16
32
2.53
2.50
1.4
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
95
340
1.42
2.50
1.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
35
99
1.79
2.42
1.7
1.4
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
43
130
1.68
2.38
1.5
1.2
umol/24h
1.8
0.6
0.91
24
53
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
96
348
1.40
2.37
1.0
1.0
u/ml
0.3
0.2
0.18
50
218
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
6
5
6.08
2.36
5.5
8.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
92
332
1.41
2.34
7.2
11.3
umol/l
0.4
0.3
1.49
81
316
(3032352) Blasts [#/volume] in Cerebral spinal fluid
79
279
1.44
2.27
2.2
3.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
55
180
1.55
2.26
1.4
1.5
umol/24h
330.3
321.8
0.11
55
180
(44786800) Granulocytes/100 leukocytes in Body fluid
76
267
1.44
2.24
1.3
1.3
%
23.7
23.9
0.01
59
205
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
10
16
3.17
2.23
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
219
900
1.23
2.23
2.1
1.7
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
25
65
1.95
2.22
1.4
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
106
396
1.36
2.21
1.6
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
264
1107
1.21
2.21
8.5
10.0
—
—
—
0
0
(3027874) Urate [Moles/volume] in Urine
28
76
1.87
2.21
1.1
1.0
mmol/l
1.7
9.8
0.51
20
48
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
160
635
1.28
2.19
1.3
1.3
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
168
672
1.27
2.17
2.1
2.7
ng/l
122.0
107.0
0.63
112
388
(3032743) Legionella sp IgG Ab [Presence] in Serum
53
174
1.54
2.16
1.0
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
51
166
1.56
2.16
3.8
6.1
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
49
158
1.57
2.15
2.3
2.3
%
12.7
17.4
0.59
27
78
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
59
199
1.50
2.14
1.1
1.0
u/ml
17.9
20.4
0.12
45
163
(3019529) Immunofixation for Cerebral spinal fluid
6
6
5.07
2.13
1.5
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
258
1567
0.83
2.12
1.4
1.3
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
26
70
1.88
2.11
1.1
1.0
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
9
14
3.26
2.10
2.7
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
3125
15053
1.05
2.08
2.3
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
472
2090
1.15
2.07
1.1
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
175
708
1.25
2.07
1.1
1.1
u/ml
1.4
2.5
—
7
27
(3027974) Hepatitis B virus e Ag [Presence] in Serum
50
164
1.55
2.06
1.5
1.5
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
13
26
2.53
2.06
1.4
1.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
78
281
1.41
2.04
2.9
3.1
mg/l
1.0
1.2
0.49
52
190
(3012494) Peanut IgE Ab [Units/volume] in Serum
244
1025
1.21
2.04
1.1
1.1
u/ml
2.6
19.1
1.11
127
639
(3012920) Ethanol [Mass/volume] in Serum or Plasma
24
64
1.90
2.01
1.3
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
343
1488
1.17
2.00
1.7
2.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
69
245
1.43
1.97
1.1
1.1
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
30
2.37
1.96
1.1
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
40
313
0.65
1.95
1.1
1.0
kpa
4.6
3.4
0.71
33
262
(21494567) Legionella sp IgM Ab [Presence] in Serum
54
183
1.50
1.94
1.0
1.2
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
16
37
2.19
1.91
1.6
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
948
4394
1.09
1.90
1.3
1.3
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
11
21
2.66
1.89
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
1707
9232
0.94
1.88
1.8
1.8
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
49
164
1.51
1.88
1.4
1.5
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
7
10
3.55
1.86
1.0
1.1
umol/l
48.6
21.3
—
7
10
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
71
257
1.40
1.84
1.3
1.2
mg/l
51.0
47.6
0.17
18
76
(3011335) Digoxin [Mass/volume] in Serum or Plasma
50
169
1.50
1.84
2.1
2.1
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
61
215
1.44
1.83
1.0
1.0
u/ml
0.8
1.9
0.70
42
163
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
47
157
1.52
1.82
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
82
305
1.36
1.82
1.1
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
36
113
1.62
1.81
2.9
2.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
230
975
1.20
1.79
1.2
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
108
420
1.30
1.79
7.4
7.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
24
67
1.82
1.79
2.2
3.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
129
514
1.27
1.78
1.2
1.2
mg/l
42.6
54.8
0.10
93
375
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
481
2160
1.13
1.77
1.2
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
459
2059
1.13
1.72
12.6
13.9
nmol/l
1970.8
1314.4
0.22
437
1993
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
26
76
1.73
1.69
1.1
1.1
mmol/l
—
—
—
0
0
(3032641) Amino acids panel - Urine
19
50
1.93
1.68
1.3
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
125
501
1.27
1.67
1.1
1.1
umol/24h
0.7
3.5
0.53
55
260
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
480
2165
1.12
1.66
17.6
19.4
nmol/l
1384.9
2890.8
1.03
461
2077
(3026926) Nortriptyline [Moles/volume] in Serum or Plasma
24
69
1.76
1.65
1.5
1.4
nmol/l
168.6
310.5
1.41
17
50
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
24
69
1.76
1.65
1.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
43
318
0.69
1.63
1.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
14
33
2.15
1.63
1.3
1.1
mmol/24h
135.9
145.1
0.24
14
33
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
22
62
1.80
1.61
5.0
5.6
mg/l
7.1
6.1
0.12
14
49
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
43
317
0.69
1.61
1.0
1.0
kpa
7.5
7.2
0.48
37
268
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
84
321
1.33
1.61
2.6
2.4
u/field
0.5
0.6
0.55
84
321
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
381
1699
1.14
1.60
1.4
1.4
mmol/l
5.7
5.5
1.83
356
1620
(1617658) Protocol used for examination of sentinel lymph nodes
320
1859
0.87
1.59
1.1
1.0
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
9
3.38
1.58
1.3
1.0
—
—
—
0
0
(3008896) Cortisol [Moles/volume] in Urine
6
9
3.38
1.58
1.0
1.3
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
6
9
3.38
1.58
1.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
53
188
1.43
1.58
1.1
1.1
u/ml
2.8
1.6
0.43
38
136
(3034092) Cytoplasmic Ig cells/100 cells in Blood
100
394
1.29
1.55
12.0
5.3
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
43
314
0.69
1.54
1.0
1.0
mmol/l
-4.7
-1.6
—
9
65
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
11
24
2.32
1.51
1.1
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
53
190
1.41
1.51
1.1
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
356
2043
0.88
1.49
1.3
1.2
g/l
1.4
1.5
0.32
19
108
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
103
410
1.27
1.49
1.2
1.2
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
44
153
1.46
1.47
1.3
1.3
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
55
200
1.39
1.45
1.1
1.1
g/l
15.1
18.2
1.99
44
181
(3000690) Aldosterone [Moles/time] in 24 hour Urine
7
13
2.73
1.45
1.1
1.3
nmol/24h
23.3
34.8
—
7
13
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
16
42
1.93
1.45
2.3
2.1
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
30
96
1.58
1.45
1.2
1.4
u/field
1.2
1.2
0.16
12
66
(3018738) Hemoglobin F/Hemoglobin.total in Blood
66
248
1.35
1.44
3.6
2.9
%
20.1
9.2
1.81
20
73
(3000764) Benzodiazepines [Presence] in Urine
3316
16172
1.04
1.40
2.3
2.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
90
357
1.28
1.36
2.2
2.4
ug/l
4.3
3.4
0.62
30
120
(3027008) Opiates [Presence] in Urine
3334
16285
1.04
1.32
2.2
2.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
564
3131
0.91
1.32
1.6
1.6
mmol/l
7.8
7.5
2.07
357
1813
(3023430) Cat dander IgE Ab [Units/volume] in Serum
883
4811
0.93
1.31
1.1
1.1
u/ml
5.8
5.6
0.06
369
2116
(3028300) Cannabinoids [Presence] in Urine
3341
16325
1.04
1.31
2.3
2.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
49
179
1.39
1.29
1.3
1.4
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
11
26
2.14
1.29
1.3
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
947
5142
0.93
1.28
1.1
1.1
u/ml
3.6
5.0
1.69
374
2153
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
7
75
0.47
1.28
4.3
5.5
mmol/l
0.2
0.2
—
7
75
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
116
479
1.23
1.27
1.8
1.8
ug/l
4.3
3.4
0.12
65
288
(3045177) Copper [Moles/volume] in Urine
15
41
1.85
1.24
1.0
1.1
umol/l
0.2
0.6
—
9
19
(3019920) Amitriptyline [Moles/volume] in Serum or Plasma
21
64
1.66
1.24
1.5
1.5
nmol/l
135.5
358.6
1.98
15
45
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
26
84
1.57
1.24
1.0
1.1
pmol/l
185.2
222.3
0.22
18
47
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
31
105
1.50
1.21
2.4
1.9
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
230
1016
1.15
1.19
1.0
1.0
u/ml
11.7
10.8
0.11
25
143
(3006567) Chloride [Moles/time] in 24 hour Urine
14
38
1.87
1.19
1.6
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
3274
16028
1.04
1.19
2.2
2.0
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
5
9
2.82
1.18
1.0
1.1
—
—
—
0
0
(3035153) Lemon IgE Ab [Units/volume] in Serum
7
14
2.53
1.17
1.0
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
30
102
1.49
1.16
1.2
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
80
321
1.26
1.15
3.2
3.3
umol/l
38.1
42.8
0.94
66
278
(3027540) Rickettsia typhi Ab [Titer] in Serum
17
50
1.72
1.14
1.1
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
13
35
1.88
1.13
1.2
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
144
617
1.18
1.12
1.2
1.3
u/ml
6.7
9.0
0.15
31
140
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
6
65
0.47
1.11
1.5
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1887
9995
0.96
1.11
1.5
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21532
107937
1.02
1.11
3.0
2.5
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
51
194
1.33
1.09
1.2
1.2
ug/l
105.3
110.1
0.10
36
116
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
31
108
1.46
1.08
10.0
9.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
63
248
1.29
1.07
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
273
1232
1.12
1.06
1.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
13
36
1.83
1.05
1.1
1.1
titre
1714.6
1883.6
0.12
13
36
(3011841) English Walnut IgE Ab [Units/volume] in Serum
94
390
1.22
1.04
1.1
1.1
u/ml
1.6
5.6
1.39
66
309
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
48
183
1.33
1.03
1.1
1.1
u/l
15.3
9.2
0.54
48
183
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
2753
13480
1.04
1.03
2.9
3.2
u/ml
42.1
46.8
0.59
2652
13023
(3005082) Progesterone [Moles/volume] in Serum or Plasma
430
1992
1.09
1.02
1.4
1.4
nmol/l
29.1
32.7
1.84
393
1845
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
445
2065
1.09
1.02
2.0
1.9
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
21
68
1.57
1.02
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
260
1173
1.12
1.02
1.8
1.9
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
58
228
1.29
1.01
1.0
1.0
u/ml
0.4
0.9
0.39
16
90
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
7
17
2.09
1.00
1.1
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
22
73
1.53
0.98
1.0
1.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
1251
6031
1.05
0.97
1.5
1.4
pmol/l
121.7
116.3
0.15
1216
5875
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
15
45
1.69
0.97
1.2
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
246
1111
1.12
0.96
2.7
2.3
nmol/l
149.2
150.2
0.05
217
948
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
13
2.34
0.95
1.0
1.2
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
6
13
2.34
0.95
1.0
1.2
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
19
62
1.55
0.91
1.2
1.4
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
15
46
1.65
0.90
1.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
40
152
1.33
0.90
6.9
8.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
142
829
0.87
0.89
1.2
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
25
88
1.44
0.87
1.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
226
1025
1.12
0.86
1.2
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
17
55
1.57
0.85
1.9
1.4
mmol/24h
1.8
2.3
0.82
17
55
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
86
364
1.20
0.83
1.1
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
64
263
1.23
0.82
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
60
374
0.81
0.81
2.3
2.6
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
30
111
1.37
0.81
1.5
1.6
u/l
0.1
0.3
—
9
32
(3025886) Oxalate [Mass/time] in 24 hour Urine
23
81
1.44
0.81
1.3
1.2
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
17
56
1.54
0.80
1.1
1.1
mu/l
74.5
46.8
0.22
12
43
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
22
77
1.45
0.80
1.0
1.0
u/ml
0.2
0.9
1.22
15
61
(3049242) von Willebrand panel - Platelet poor plasma
22
77
1.45
0.80
1.3
1.9
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
25
90
1.41
0.79
1.0
1.1
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
81
343
1.20
0.79
1.0
1.1
u/ml
0.2
0.6
1.65
43
188
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
153
682
1.14
0.79
1.1
1.2
u/ml
1.6
9.4
3.69
105
494
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
78
469
0.84
0.75
1.2
1.1
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
37
144
1.30
0.74
1.8
1.9
umol/l
0.7
0.6
0.20
26
111
(3017958) Strawberry IgE Ab [Units/volume] in Serum
24
87
1.40
0.74
1.0
1.0
u/ml
0.0
0.2
0.85
14
52
(3046914) Granular casts [#/area] in Urine by Computer assisted method
12
37
1.64
0.73
1.3
1.4
u/field
1.0
0.6
—
5
21
(40758292) HTLV I+II Ab panel - Serum
116
511
1.15
0.72
1.4
1.4
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
21
75
1.42
0.70
1.0
1.1
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
20
71
1.43
0.69
1.3
1.2
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
88
381
1.17
0.69
1.0
1.1
u/ml
0.2
3.3
1.16
42
204
(3017509) Phencyclidine [Presence] in Urine
99
433
1.16
0.69
1.8
1.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
97
424
1.16
0.68
5.5
5.5
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
1144
6036
0.96
0.67
1.1
1.1
u/ml
1.8
2.6
1.18
278
1625
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
775
4124
0.95
0.66
1.0
1.1
u/ml
0.4
0.5
0.13
181
951
(3029396) Erythrocyte agglutination [Presence] in Blood
232
1075
1.09
0.64
2.8
3.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
29
190
0.77
0.64
1.0
1.0
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
8
25
1.62
0.62
1.4
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
16
114
0.71
0.61
1.0
1.0
—
—
—
0
0
(43055459) Dabigatran [Mass/volume] in Serum or Plasma
19
69
1.40
0.60
1.7
1.7
ug/l
86.0
135.3
1.16
11
44
(3020874) Milk IgE Ab [Units/volume] in Serum
453
2164
1.06
0.58
1.1
1.1
u/ml
3.2
2.9
0.05
146
688
(4281824)
508
2721
0.95
0.58
1.2
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
52
219
1.20
0.58
1.1
1.2
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
9
29
1.57
0.57
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
1242
6515
0.97
0.57
1.7
1.7
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
89
394
1.15
0.56
1.1
1.1
u/ml
0.3
3.3
5.09
62
310
(46235168) Fasting glucose [Moles/volume] in Blood
68
400
0.86
0.55
4.8
1.2
mmol/l
8.5
7.0
1.26
41
117
(3003577) Lead [Moles/volume] in Blood
42
257
0.83
0.54
1.4
1.4
umol/l
0.2
0.2
0.04
15
88
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
216
1009
1.09
0.53
1.0
1.0
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
85
377
1.14
0.53
1.0
1.1
u/ml
0.1
0.8
1.51
41
205
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
62
366
0.86
0.53
9.8
7.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
123
560
1.11
0.52
1.1
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
318
1511
1.07
0.51
6.0
6.1
u/ml
1087.0
3260.2
0.52
57
327
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
14
50
1.42
0.50
1.0
1.1
%
2.2
2.8
0.52
14
50
(40768793) Breast Pathology biopsy report
1081
5655
0.97
0.46
1.3
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
1467
7637
0.97
0.45
1.5
1.5
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
8
27
1.50
0.45
1.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
118
0.77
0.44
1.2
1.0
—
—
—
0
0
(3027114) Cholesterol [Mass/volume] in Serum or Plasma
0
8
0.00
0.43
0.0
1.0
—
—
—
0
0
(3017501) Neutrophils [#/volume] in Blood by Manual count
0
9
0.00
0.43
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5366
26848
1.01
0.43
2.0
2.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
33
138
1.21
0.43
17.5
6.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
442
2137
1.05
0.42
1.1
1.1
u/ml
4.0
4.3
0.06
129
600
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
26
106
1.24
0.42
1.0
1.0
u/ml
0.1
0.4
0.88
11
56
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
20
79
1.28
0.41
1.2
1.2
ng/l
7955.8
2309.9
0.73
12
56
(3007456) Orange IgE Ab [Units/volume] in Serum
18
70
1.30
0.41
1.0
1.0
u/ml
0.0
0.2
—
9
44
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
25
102
1.24
0.41
1.0
1.0
u/ml
0.7
0.5
—
10
49
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
5
17
1.49
0.41
1.0
1.0
—
—
—
0
0
(4038314)
64
286
1.13
0.40
1.2
1.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
9
33
1.38
0.39
1.0
1.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
18
71
1.29
0.38
1.1
1.2
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
6
20
1.52
0.37
3.0
5.0
—
—
—
0
0
(3021661) Pineapple IgE Ab [Units/volume] in Serum
11
40
1.39
0.37
1.0
1.1
u/ml
0.2
0.1
—
5
21
(4133840)
183
867
1.07
0.37
1.2
1.2
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
6
21
1.45
0.36
1.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
315
1678
0.95
0.36
1.6
1.4
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
11
41
1.36
0.33
1.5
1.3
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
45
200
1.14
0.32
1.0
1.0
u/ml
1.1
0.5
0.53
36
186
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
33
144
1.16
0.30
1.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
47
211
1.13
0.30
1.7
1.8
umol/l
45.5
44.2
0.11
47
211
(40762887) Creatinine [Moles/volume] in Blood
13
51
1.29
0.29
1.2
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
896
4431
1.03
0.29
1.4
1.4
mmol/l
7.3
7.0
1.89
655
3156
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
9
61
0.75
0.28
1.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
478
2345
1.03
0.28
1.8
1.4
g/l
0.9
0.9
0.05
478
2326
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
4288
21513
1.01
0.27
1.9
1.9
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
23
137
0.85
0.27
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
74
408
0.92
0.26
1.3
1.4
—
—
—
0
0
(3013862) HLA-DP [Type]
25
109
1.16
0.24
1.0
1.0
—
—
—
0
0
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
22
95
1.17
0.24
1.0
1.0
u/ml
0.2
1.1
—
8
51
(3034614) HLA Ag [Interpretation]
16
67
1.21
0.23
1.3
1.2
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
5
20
1.27
0.23
1.6
1.8
%
2.2
18.0
—
5
20
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
5
20
1.27
0.23
1.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
12
75
0.81
0.22
5.9
6.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
29
129
1.14
0.22
1.3
1.1
—
—
—
0
0
(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.22
0.0
4.0
—
—
—
0
0
(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
55
255
1.09
0.22
1.1
1.1
u/ml
0.3
1.0
3.42
30
164
(3045759) Histamine [Moles/volume] in Serum or Plasma
5
21
1.21
0.22
1.6
1.5
—
—
—
0
0
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
7
0.00
0.22
0.0
3.9
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
53
246
1.09
0.21
1.1
1.1
u/ml
3.8
10.1
3.69
39
165
(3007542) Rye IgE Ab [Units/volume] in Serum
39
178
1.11
0.21
1.1
1.0
u/ml
1.8
10.2
0.40
13
89
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
38
213
0.90
0.20
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
1175
6050
0.98
0.20
1.1
1.1
u/ml
1.0
1.2
0.54
522
2729
(3013762) Body weight Measured
21
122
0.87
0.19
1.1
1.1
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
58
272
1.08
0.19
1.0
1.0
u/ml
0.8
1.6
0.45
37
186
(40760409) HLA-A [Type] by High resolution
24
107
1.14
0.19
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
24
107
1.14
0.19
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
957
4774
1.02
0.18
1.5
1.5
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
7
31
1.14
0.18
1.1
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
55
259
1.08
0.17
1.1
1.1
umol/24h
1.8
3.2
0.49
55
259
(3040794) Aluminum [Moles/volume] in Urine
10
41
1.24
0.17
1.2
1.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
19
84
1.15
0.16
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
24
109
1.12
0.15
1.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
33
182
0.92
0.14
1.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
430
2223
0.98
0.14
3.5
3.9
u/ml
41.9
50.1
0.56
425
2204
(3015076) Soybean IgE Ab [Units/volume] in Serum
377
1948
0.98
0.12
1.0
1.1
u/ml
0.4
0.9
1.17
61
300
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
79
418
0.96
0.11
1.2
1.2
mmol/l
20.2
20.4
0.17
60
360
(3032868) Hemoglobin electrophoresis panel in Blood
61
295
1.05
0.10
1.6
1.6
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
5
23
1.10
0.10
2.8
1.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
1379
7044
0.99
0.10
1.1
1.1
u/ml
1.8
1.8
0.02
562
3049
(3025296) Carrot IgE Ab [Units/volume] in Serum
14
63
1.13
0.10
1.0
1.0
u/ml
0.2
1.3
—
5
37
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10309
52384
1.00
0.09
2.9
2.9
ug/l
0.7
0.8
3.54
6718
33122
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
17
95
0.91
0.09
1.2
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
24
131
0.93
0.09
1.0
1.1
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
11
49
1.14
0.08
1.0
1.1
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
11
49
1.14
0.08
1.1
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
903
4540
1.01
0.08
3.3
2.2
%
13.2
13.1
2.28
892
4480
(3021691) Plasmodium malariae Ab [Titer] in Serum
6
37
0.82
0.08
2.3
2.2
—
—
—
0
0
(40758358) Immune stain study
19
104
0.93
0.07
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
23
109
1.07
0.07
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
236
1183
1.01
0.04
1.1
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
44
230
0.97
0.04
1.0
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
1248
6346
1.00
0.03
1.1
1.1
u/ml
6.5
5.8
0.50
659
3433
(3025130) Human papilloma virus identified in Specimen
847
4276
1.00
0.03
1.8
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
2309
11678
1.00
0.03
1.8
1.6
mg/l
4.2
3.3
3.16
1743
7800
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
60
298
1.02
0.03
1.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
33
165
1.01
0.00
1.0
1.0
u/ml
1.7
8.3
0.39
12
91
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
49
249
1.00
0.00
1.3
1.4
u/ml
8.7
6.0
0.19
44
204
(44806420)
128
647
1.00
0.00
2.3
2.3
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
14
68
1.04
0.00
1.0
1.3
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
32
160
1.01
0.00
1.5
1.2
—
—
—
0
0
(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
7
37
0.96
0.00
1.1
1.3
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
7
38
0.93
0.00
1.1
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
7
35
1.01
0.00
1.1
1.0
—
—
—
0
0
(3032642) Schistosoma sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
7
37
0.96
0.00
1.1
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_THYROID_CTRL_EXCLUSION – Used for control exclusion in common control thyroid runs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).